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Abstract 
 
In frogs, part of the important immune defence system of their skin is the secretion of 
antimicrobial peptides from granular glands. This study investigated the immune function of 
skin peptides in protection against bacterial pathogens associated with infectious bacterial 
dermatosepticemia under a number of environmental conditions and at certain stages of the life 
cycle of frogs. The natural peptide mixture of skin peptides was collected from skin secretions 
of three semi-aquatic Litoria frog species L. aurea, L. raniformis and L. ewingii and aquatic 
Xenopus laevis and assayed for activity against the bacterial pathogens: Aeromonas hydrophila, 
Chryseobacterium meningosepticum, Citrobacter freundii, Klebsiella pneumoniae, Proteus 
mirabilis, Pseudomonas aeruginosa and Serratia liquefaciens. The peptide mixtures of three 
frog species Xenopus laevis, Litoria aurea and Litoria raniformis showed activity against C. 
freundii, C. meningosepticum, K. pneumoniae and P. aeruginosa in vitro indicating a likely 
protective function. One Litoria species, L. ewingii, had a peptide mixture that did not have 
activity against any pathogen. Subsequently, in experimental exposure of animals to the 
pathogen K. pneumoniae, this species was found to be susceptible to disease while the other 
sympatric species L. raniformis was found to be resistant. A strong correlation was shown 
between composition of skin peptides and resistance to disease.  
 
A comparison of the production and activity of skin peptides from four frog species showed the 
aquatic X. laevis to have more effective immune defence against bacterial pathogens than three 
tested Litoria species. X. laevis produced significantly greater amount of bioactive peptide 
mixture than three tested Litoria species. 
  ii
Three pathogens A. hydrophila, P. mirabilis and S. liquefaciens are abundant 
components of the skin microbiota of healthy frogs and were found to be resistant to 
the peptide mixtures of all four frog species tested. It was shown that one pathogen, A. 
hydrophila, had the ability to secrete proteases which could inactivate skin peptides. 
Thus while skin peptides could function against several pathogens, some pathogens 
might have co-evolved to resist skin peptides.  
 
A comparison of the peptide mixtures from skin secretions of adults, metamorphs and 
larvae of L. ewingii using liquid chromatography-mass spectrometry analyses showed 
that peptide mixtures of post metamorphic animals, adults and metamorphs, had a 
species-specific profile that included the antimicrobial peptide uperin 7.1, while the 
larval peptide mixture did not contain uperin 7.1 or any other known species-specific 
peptide. This finding indicates the absence of a secretory mechanism that could 
compensate for the absence of granular glands in larvae.  
 
Analyses of the production and activity of skin peptides of L. raniformis after 
exposure to two different environmental stressors, low environmental temperature and 
pesticide carbaryl, showed that the total amount of bioactive peptide was significantly 
reduced which could consequently increase susceptibility to disease. Thus suppression 
of skin peptides could be a possible mechanism for synergism between the important 
stressors and pathogens in disease development.
  iii
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Chapter 1: Introduction 
 
1.1 The Significance of Research on the Immune System of Frogs 
Research on the immune system of frogs and other amphibians is an area of growing scientific 
interest. The interest is due to the association between infectious disease and declines of 
amphibian populations, which have occurred in both pristine and compromised habitats on all 
six continents (Carey, et al., 1999, Daszak et al., 1999). While chytridiomycosis, a fungal 
disease of skin caused by the chytrid fungus Batrachochytrium dendrobatidis, has received 
much attention in Australia and Central America (Berger et al., 1998), other viral and bacterial 
diseases have been observed. In Great Britain, disease caused by Ranavirus (Iridoviridae) has 
been associated with mortality of the Common Frog (Rana temporaria) (Cunningham et al., 
1996). The opportunistic bacterium Aeromonas hydrophila is associated with bacterial 
dermatosepticemia, a systematic bacterial disease that caused local population die-offs of two 
Rana species, R. muscosa and R. sylvatica (Nyman, 1986, Bradford, 1991). Other bacteria 
associated with mortality, especially among captive populations, are different Gram-negative 
species including Chryseobacterium indologenes, Chryseobacterium meningosepticum, 
Citrobacter freundii, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aerugionsa and 
Serratia liquefaciens (Glorioso et al., 1974, Anver and Pond, 1984, Olson et al., 1992, Taylor et 
al., 2001).  
 
Emergence of these diseases in wild populations of frogs was surprising as all of the pathogens 
associated with disease are also found in healthy animals indicating their immune systems are 
sufficiently protective against these pathogens to establish a co-evolutionary 
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relationship with them (Hird et al., 1981, Pearson, 1998, Cullen and Owens, 2002, Schlaepfer et 
al., 2007). The wide range of pathogens and their relationship with their hosts suggests that 
disease itself cannot exclusively explain global declines of frog populations and other factors 
need to be considered. Stressors associated with decline of frogs in areas affected by disease, 
such as climate change and air-born pollutants, could suppress the immune systems of wild 
frogs and increase susceptibility to disease (Drost and Fellers, 1996, Blaustein et al., 1998, 
Beecher, 2006, Alford et al., 2007, Davidson and Knapp, 2007). Research on the functions of 
frog immune systems against invading pathogens and the effects of stressors on these immune 
systems should lead to a better understanding of the mechanisms of disease development and 
subsequent decline of frog populations.  
 
1.2 The Immune System of Frogs 
Frogs have the full complement of immune systems as higher vertebrates including both 
adaptive and innate immunity (Du Pasquier et al., 1989, Carey et al., 1999, Woodhams et al., 
2007). Innate immunity involves different mechanisms that can provide an instant response 
nonspecifically to many different pathogens. In frogs, the innate immune defences include 
antimicrobial peptides (Simmaco et al., 1998, Rollins-Smith et al., 2005), a complement lytic 
system (Green and Cohen, 1977), phagocytic macrophages, granulocytes (Manning and Horton, 
1982) and natural killer cells (NK cells) (Horton et al., 1996). As in other vertebrates, the 
adaptive immunity of frogs responds to previously encountered pathogens by recognition of 
their antigens. Its cellular components include different kinds of lymphocytes while its 
extracellular component (humoral component) includes specialized immunoglobulin proteins 
(antibodies) which are produced in specialized lymphocytes (B cells) (Du Pasquier et al., 
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1989). It also includes two different protein complexes called major histocompatibility complex 
(MHC) I and II for presentation of endogenously and externally derived antigens respectively 
(Du Pasquier et al., 1989). The MHC I proteins are expressed on the membrane of every single 
cell of the bodies of adult frogs while the MHC II proteins are expressed on the limited number 
of T and B cells and the specialized macrophages called “antigen presenting cells” (Du 
Pasquier and Flajnik, 1990). Although frogs do not have lymph nodes and bone marrow, they 
do have a thymus and a spleen, which serve as central and peripheral lymphoid organs 
respectively. Therefore, frogs possess an immune system similar to higher vertebrates, 
including humans and other mammals. 
 
Although the adaptive immune system of frogs has all components of the mammalian adaptive 
immune system, its responses to invading pathogens are too slow to evolve to provide sufficient 
protection in skin of poikilothermic animals like frogs whose physiological processes depend 
on the environmental temperature (Simmaco et al., 1998, Carey et al., 1999). Similarly, 
humoral innate immunity, including complement mediated effects, cannot provide protection 
from invading bacteria in frogs (Green and Cohen, 1977, Simmaco et al., 1998). Therefore, the 
specialised innate immune defences of skin such as the antimicrobial peptides might be 
essential in protection from invading pathogens. 
 
1.3 Skin Antimicrobial Peptides  
Antimicrobial peptides are found in microorganisms, plants, insect haemolymph, and the lungs, 
gastrointestinal tract and intestinal cells of mammals, as well as in frog skin secretions (Bevins 
and Zasloff, 1990, Barra and Simmaco, 1995, Rinaldi, 2002).  
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Frogs have two types of skin glands that are located in the dermis: granular and mucous glands 
(Fig. 1) (Duellman and Trueb, 1986, Stebbins and Cohen, 1995, Shepherd et al., 1998). The 
function of mucous glands is to secrete mucus to keep the skin continuously moist for efficient 
respiration and thermoregulation (Duellman and Trueb, 1986, Stebbins and Cohen, 1995). 
Mucous and granular glands may occur in aggregations, or as macroglands visible as raised 
areas of skin described variously as parotid glands or dorsolateral folds of some species 
(Duellman and Trueb, 1986, Tyler, 1987). Many frog species lack these aggregations, and in 
these species glands are distributed evenly throughout the integument (Duellman and Trueb, 
1986, Steinborner et al., 1997). 
 
Fig. 1. Skin glands of adult Australian Southern Bell Frog (Litoria raniformis). 
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Antimicrobial peptides are synthesized in granular glands (Duellman and Trueb, 1986, 
Erspamer, 1994, Shepherd et al., 1998) and secreted onto the skin surface in response to stimuli 
of sympathetic nervous system such as electric shock, administration of norepinephrine, injury, 
predation, handling or other stressors (Tyler et al., 1992, Rollins-Smith et al., 2002, 
Woodhams, 2003). As skin secretions have many possible functions such as defence against 
predators, mediation of pain and wound healing, in addition to antimicrobial peptides, the 
secretory epithelial cells also synthesize a variety of other peptide and non-peptide compounds 
that may function as toxins, hormones and neurotransmitters (Bevins and Zasloff, 1990, 
Barthalmus, 1994, Erspamer, 1994, Doyle et al., 2002). All of these compounds are stored as 
deposits in the lumen of granular glands and secreted together with antimicrobial peptides by 
the mechanism of holocrine secretions (Erspamer, 1994). After depletion, the deposits of skin 
peptides may be restored within 6 days to 2 weeks (Erspamer, 1994, Rollins-Smith et al., 
2005). 
 
Skin peptides, identified by their ability to inhibit microbial growth, have been isolated from 
skin secretions of  frog species belonging to 11 different genera including Ascaphus, Bombina, 
Bufo, Crinia, Hyla, Leptodactylus, Litoria, Phyllomedusa, Rana, Uperoleia and Xenopus 
(reviewed in Pukala at el. 2006). In general, they are small peptides (11-40 amino acid 
residues) that have a positive net charge (reviewed in Pukala at el. 2006). They function by 
binding the negatively charged components of the membranes of different microbial cells and 
forming α-helical structures which cause perturbation of membranes and cell lysis (Zasloff, 
1987, Matsuzaki et al., 1995, Shai, 2002). They have been shown to have activity both against 
frog invading pathogens B. dendrobatidis and Ranavirus and different human bacterial 
pathogens (Zasloff, 1987, Chinchar, et al., 2001, Rollins-Smith et al., 2002, Chinchar, et al., 
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2004, Woodhams et al., 2006, Woodhams et al., 2007). To date, however, only peptides of the 
African Clawed frog (Xenopus laevis), including magainin 2, and peptides with amino-terminal 
glycine (PGLa), have been tested for activity against one bacterium pathogenic to frogs, A. 
hydrophila (Rollins-Smith et al., 2002). The activity of these peptides against other bacterial 
pathogens, and activities of other skin peptides from all other species, have not previously been 
investigated.  
 
Frog skin secretions contain a mixture of different peptides that have activity against invading 
pathogens (Simmaco et al., 1998, Rollins-Smith et al., 2002, Rollins-Smith et al 2005, 
Woodhams et al., 2006, Woodhams et al., 2007). The action of the peptide mixture is thought 
to be more important in protection against bacterial pathogens than the action of any single 
peptide component, with possible synergistic effects occurring (Westerhoff et al., 1995, 
Rollins-Smith et al., 2002). As each frog species secretes its own unique set of peptides, 
significant variation occurs among species in the number, structure and antimicrobial activity of 
these peptides (Vanhoye et al., 2003, Conlon et al., 2004).  
 
On skin surface, the regulatory mechanism of activation of skin peptides involves proteases. 
The peptides are synthesized as large precursor peptides; after synthesis, a signal sequence is 
removed from the precursor peptides by an endoprotease and the smaller bio-inactive peptide is 
transported and stored in the granular glands. The peptide is activated by another protease when 
released from granular glands. In order to prevent self-injury, a third endoprotease deactivates 
the peptides within 15-30 minutes (Resnick, et al., 1991, Steinborner et al., 1997, Bowie et al. 
1999). It is possible that some bacteria that are resistant to skin peptides could produce 
proteolytic enzymes that could inhibit the antimicrobial activity by degrading skin peptides, 
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although proteases and other possible mechanism of resistance of pathogens to skin peptides 
have not been previously investigated.  
 
1.4 Association of Impaired Immune Defences with Life Stage 
Immune systems of larvae and adult frogs are different with regard to responses to invading 
pathogens. The responses of the adaptive immune defences of larvae are impaired compared to 
adults because of the low efficiency of antibodies and absence of expression of MHC I proteins 
(Flajnik et al., 1986, Flajnik et al., 1987, Pross and Rowlands, 2005). Such regulations of the 
immune defences are required to prevent autoimmune processes against the tissues that emerge 
in metamorphosis such as lung tissues, skin dermis and in other organs, although they increase 
susceptibility to intracellular pathogens such as Ranavirus (Carey et al., 1999). 
As secretion of skin antimicrobial peptides from granular glands is fully developed after 
completion of metamorphosis, the innate immune defences of larvae may also be different to 
those in adults. The resistance of larvae to extracellular pathogens suggests that some other 
secretion mechanism might exist in place of granular glands. Some experimental studies have 
shown that small serous epidermal glands of tadpoles could secrete peptides (Liem, 1961, 
Delfino, 1991, Richards, 1992, Delfino et al., 2007). Synthesis of peptides in the skin of the 
Magnificent Tree Frog (Litoria splendida) tadpoles starts well before the onset of 
metamorphosis (Wabnitz et al. 1998). Woodhams (2003) collected skin secretions from 
tadpoles of three Australian species: Litoria nannotis, Litoria genimaculata and Mixophyes 
shevilli for studies with chytrid fungi but did not analyse them chemically. Secretions from 
tadpole skins require further characterisation in order to establish their role in innate immunity. 
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1.5 Frog Stressors 
Stress is the effect of any force which tends to extend any homeostatic or stabilizing process 
beyond its normal limit, at any level of biological organization (Esch et al., 1975). Its cause, the 
stressor, may be either an anthropogenic or environmental, but such factors are not labeled 
“stressors” unless a stress (effect or response) is identified. “Anthropogenic stressors” of frogs 
may include habitat fragmentation, global climate change, pollution and captivity (Drost and 
Fellers, 1996, Beecher, 2006, Alford et al., 2007, Davidson and Knapp, 2007). “Environmental 
stressors” of frogs include temperature fluctuation, hydric conditions, diet, social and species 
interactions, ecosystem interactions and disease (Carr et al., 1976, Wright et al., 1999, Relyea 
and Mills, 2001, Glennemeier and Denver 2002). Responses to different stressors involve 
changes in physiological processes that act to adapt and regain homeostasis.  
 
Since responses to stressors may affect susceptibility to disease and the worldwide decline of 
frogs, some studies have been undertaken to investigate how they could influence the immune 
defences. It has been found that frogs have a hormonal mechanism conserved among different 
vertebrates that includes elevation of corticosteroid hormones in response to a variety of 
environmental and anthropogenic stressors, which in turn could affect many different 
physiological functions of importance for survival such as immune and reproductive functions 
(Rollins-Smith et al., 1997, Wright et al., 1999, Hayes et al., 2003). Corticosteroids can 
influence the immune responses in various ways including reducing the number of lymphocytes 
(Rollins-Smith et al., 1997), altering immune cell trafficking, leukocyte infiltration into sites of 
inflammation (McEwen et al. 1997, Chrousos, 1998, Marques-Deak et al., 2005), synthesis of 
skin peptides (Simmaco et al., 1997, Miele et al., 1998, Simmaco et al., 1998) and expression 
of MHC I and II proteins (McEwen et al. 1997, Chrousos, 1998, Marques-Deak et al., 2005). In 
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general, they are thought to cause suppression of immune responses (immune-suppression) and 
thereby increase susceptibility to invading pathogens.  
 
1.6 Stress Mediated Suppression of Skin Antimicrobial Peptides 
In response to a variety of environmental and anthropogenic stressors, frogs secrete 
corticosteroids that can inhibit synthesis and release of antimicrobial peptides (Rollins-Smith et 
al., 1997, Simmaco et al., 1997, Miele et al., 1998, Simmaco et al., 1998). Inhibition of skin 
peptides mediated by corticosteroids involves increased activity of inhibitors of the NF-κB 
transcription factor, which is involved in the activation of genes encoding for skin peptides 
(Miele et al., 1998, Mangoni et al., 2001). At low environmental temperature, the total amount 
of recovered peptides of L. genimaculata is significantly reduced (Woodhams, 2003). Gibble 
(2006) found that the efficiency of skin peptides of X. laevis has been significantly reduced 
after exposure to atrazine. The presence of pathogens may also affect synthesis of skin peptides 
as the synthesis of skin peptides by frogs infected with chytrid fungi is significantly increased 
(Woodhams, 2003). Bathing frogs in bacterial cultures caused a significant increase in synthesis 
of skin peptides by Bombina orientalis and Rana esculenta frogs except when they had been 
treated with corticosteroids (Miele et al., 1998, Simmaco et al., 1998). 
 
Other stressors may induce the release of skin peptides from granular glands. Davidson et al. 
(2007) showed that exposure of Rana boylii frogs to the carbamate pesticide carbaryl, which is 
known to cause prolonged stimulation of release of skin peptides from granular glands, caused 
a significant decrease in total amount of bioactive peptides on skin surface. Alternatively, it 
might be also possible that an overall response to stressors could trigger secretion of 
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catecholamines that in turn could increase the release of skin peptides from granular glands 
(Davidson et al., 2007).  
 
Although stressors could inhibit skin peptides and increase susceptibility to opportunistic 
pathogens, their effects on frogs have not been analysed in vivo. Further progress in 
understanding the synergism between pathogens and stressors in disease development could be 
obtained by analyses of skin antimicrobial peptides and susceptibility to disease in studies 
including the simultaneous exposure of frogs to pathogen and stressor. 
 
Inhibition of skin peptide may also occur naturally, immediately after completion of 
metamorphosis. The high concentrations of corticosteroids in blood of metamorphs associated 
with the avoidance of early activation of the immune responses that could potentially trigger 
autoimmune reactions against newly emerged tissues can also inhibit the synthesis skin 
peptides (Rollins-Smith et al., 1997, Simmaco et al., 1997, Rollins-Smith, 1998, Simmaco et 
al., 1998). Inhibition of skin peptides could be directly responsible for the high susceptibility of 
metamorphs to invading pathogens (Woodhams, 2003). This, however, has not been tested 
experimentally.  
 
1.7 Objectives 
Amongst different diseases, bacterial dermatosepticemia is the most common disease in many 
different frog species (Taylor et al., 2001). As bacteria enter the body through the skin, disease 
development depends on pathogen virulence and environmental factors but is modulated by the 
immune defences of the host (Glorioso et al., 1974, Pearson, 1998). The responses of adaptive 
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and humoral innate immunity are slow to evolve to provide protection from invading bacteria 
(Green and Cohen, 1977, Simmaco et al., 1998, Carey et al., 1999). This thesis was undertaken 
to explore whether skin peptides could have a role in protecting frogs from bacterial pathogens 
and how different factors such as phylogeny of frogs, pathogens, low environmental 
temperature, life stage and pesticides could influence their production and activity. The frog 
species used were the aquatic African Clawed Frog (X. laevis) and three semi-aquatic native 
Australian Litoria species that were naturalized in New Zealand through introductions in the 
nineteenth century: Green and Golden Bell Frogs (L. aurea), Southern Bell Frogs (L. 
raniformis), and Brown Tree Frogs (L. ewingii).  
 
The specific objectives of the study were:  
1) To characterise the activity of skin peptides of different frog species against different 
bacterial pathogens in vitro. 
2) To determine whether low environmental temperature affects the production and activity of 
skin peptide of frogs. 
3) To analyse how the activity of skin peptides differs with the life stage of frogs. 
4) To determine whether the extracellular products of bacterial pathogens could modulate the 
activity of skin peptides in vitro. 
5) To investigate relationship between activity of skin peptides and resistance to disease in an 
animal model that includes exposure to pathogens. 
6) To determine whether the exposure to pesticide carbaryl could modulate the production and 
activity of skin peptides, and resistance to disease of frogs. 
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Chapter 2: Activity of Skin Peptides Against Bacterial Pathogens 
 
2.1 Introduction 
Bacterial dermatosepticemia is a fatal infectious bacterial disease of frogs. Most frequently it is 
caused by the bacterium Aeromonas hydrophila (Hunsaker and Potter, 1960, Nyman, 1986, 
Pearson et al., 2000, Taylor et al., 2001) but some other bacterial species including 
Chryseobacterium indologenes, Chryseobacterium meningosepticum, Citrobacter freundii, 
Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis and Serratia liquefaciens 
have also been recorded as able to cause this disease (Glorioso et al., 1974, Anver and Pond, 
1984, Olson et al., 1992, Taylor et al., 2001). All bacterial species associated with this disease 
are opportunistic pathogens that are found in the skin and gut microbiota of healthy frogs but 
are known to cause disease (Hird et al., 1981, Taylor et al., 1993, Taylor et al., 2001). Chronic 
stressors such as pesticides, temperature fluctuation and crowding can compromise the immune 
system of amphibians and increase disease susceptibility (Rigney et al., 1978, Carey and Bryant 
1995, Taylor et al., 2001, Hayes et al., 2006). This increased susceptibility can lead to 
emergence of epizootic outbreaks of disease (Carey and Bryant 1995, Taylor et al., 2001, 
Hayes et al., 2006) associated with high mortality both in wild and captive populations 
(Nyman, 1986, Bradford, 1991, Taylor et al., 1993, Mauel et al., 2002).  
 
The high mortality that is associated with this disease is attributable to bacterial toxaemia, 
which appears to be the proximate cause of death (Glorioso et al., 1974, Rigney et al., 1978, 
Taylor et al., 2001). Bacterial invasion through the skin leads to generalised bacteremia with 
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elaboration of toxins (Glorioso et al., 1974, Rigney et al., 1978). Constant release of bacterial 
toxins causes extensive tissue necrosis, hyperemia, oedema and haemorrhage in many internal 
organs leading to death (Glorioso et al., 1974, Rigney et al., 1978). Since haemorrhage and 
erythema can be seen as reddening of the ventral hindlimb skin, a common public misnomer, 
“Red-leg syndrome”, was given to the epizootic form of the disease (Emerson and Norris, 
1905), though reddening of the skin can be seen in other diseases too (Taylor et al., 2001). 
 
Upon bacterial entry through the skin disease development may be influenced by many 
different environmental and microbial factors, but is modulated by the immune defence of the 
host (Glorioso et al., 1974, Pearson, 1998). Like in other vertebrates, frog skin immunity 
involves adaptive and innate immune defences (Carey et al., 1999). The adaptive immune 
system includes inflammatory responses to specific antigens presented by macrophages and 
dendritic cells, and is mediated by specific antibodies and T-lymphocytes (Du Pasquier and 
Flajnik, 1990). The skin might also be protected from microbial pathogens by innate immune 
defences that include macrophages and neutrophils (Manning and Horton, 1982), the 
complement system that lyses the pathogen (Green and Cohen, 1977), natural killer cells 
(Horton et al., 1996) and antimicrobial peptides (Simmaco et al., 1998, Rollins-Smith et al., 
2005). As frogs are poikilothermic animals, the inflammatory responses are too slow to develop 
at a sufficient rate to protect against large numbers of bacteria invading the skin (Simmaco et 
al., 1998, Carey et al., 1999). Similarly, humoral innate immunity, including complement 
mediated effects, cannot provide protection from invading bacteria in frogs (Green and Cohen, 
1977, Simmaco et al., 1998). Thus, other mechanisms of the innate immune defences, including 
skin peptides, may be essential in protection from bacterial pathogens.  
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Some experimental studies have shown that secretion of antimicrobial peptides from specialised 
granular glands can provide protection against microbial pathogens (Simmaco et al., 1998, 
Rollins-Smith et al., 2002b, Woodhams et al., 2006). Isolated antimicrobial peptides of a 
variety of frog species were shown to have activity against standard reference bacterial strains 
(reviewed in Pukala et al., 2006). However, so far only peptides of the African Clawed frog 
(Xenopus laevis), including magainin 2, and peptides with amino-terminal glycine (PGLa), have 
been tested for activity against A. hydrophila, (Rollins-Smith et al., 2002a). The activity of 
these peptides against other pathogens, and activities of other skin peptides from all other 
species, have not been investigated.  
 
Skin peptides are secreted as a mixture of different peptides that have activities that could 
protect against invading pathogens (Simmaco et al., 1998, Boman, 2000, Rollins-Smith et al., 
2002b, Woodhams et al., 2006). The activity of the peptide mixture are thought to be more 
important in protection against bacterial pathogens than the activities of single peptide, with 
possible synergistic effects occurring (Westerhoff et al., 1995, Rollins-Smith et al., 2002a). As 
each frog species secretes its own unique set of peptides, significant variation occurs among 
species in the number, structure and antimicrobial activity of these peptides (Vanhoye et al., 
2003, Conlon et al., 2004). Consequently the immune defences of different frog species will 
vary and variation in susceptibility to pathogens occur.  
 
The objective of this study was to characterise the activities of skin peptides against different 
bacterial pathogens in vitro. Peptides were collected from four different frog species including 
the aquatic African Clawed Frog (Xenopus laevis) and three semi-aquatic native Australian 
Litoria species that were naturalized in New Zealand through introductions in the nineteenth 
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century: Green and Golden Bell Frogs (L. aurea), Southern Bell Frogs (L. raniformis), and 
Brown Tree Frogs (L. ewingii).  
 
2.2 Materials and Methods  
2.2.1 Collection and purification of skin peptides 
Skin secretions were collected from ten adult animals of L. aurea, L. raniformis and L. ewingii, 
and one adult X. laevis, all of which were maintained in natural conditions in a vivarium at the 
School of Biological Sciences, University of Canterbury. Collections were made between 
August and October 2005. Animals were initially dosed with norepinephrine by subcutaneous 
injection as described by Rollins-Smith et al. (2002b). This method was designed to provide a 
standardised stimulus to induce secretions from a variety of species and to avoid the more 
painful electrostimulation procedure, which requires calibration for each species. Each animal 
was weighed, injected with 2 nmol per 1 g of body mass of norepinephrine (bitartrate salt, 
Sigma, St. Louis, Missouri, USA) and placed in a plastic bag containing 10 ml collection buffer 
per gram body weight (50 mM sodium chloride, 25 mM sodium acetate, pH 7.0) for 10 min 
while secretions accumulated. After removal of animals from the bags, the collection buffer 
containing skin peptides was acidified by addition of concentrated HCl to a final concentration 
of 1% to inhibit protease, filtered through a Millex HV filter unit (0.45 µm) and stored at –80ºC 
until lyophilisation. The lyophilised samples were redisolved to in distilled deionised water 
(ddH2O) give concentration of peptides of 1 mg/ml and passed over C18-Sep-Pak cartridges 
(Waters Corporation, Milford, MA, USA). Peptides in the molecular weight range of 500-
10,000 Da were retained on the Sep-Pak cartridges, while other peptides were discarded. 
Peptides bound to Sep-Pak were eluted with 70% acteonitrile, 29.9% water and 0.1% 
trifluoroacetic acid (TFA) and skin peptide samples were lyophilised and stored at –80ºC. At 
Chapter 2: Activity of skin peptides against bacterial pathogens 
 26
the end of each experiment, the samples were redisolved in ddH2O and combined to make the 
final stock solution. Peptide concentrations were determined by Micro BCATM Assay (Pierce 
Rockford, Illinois, USA) following the manufacturer’s instructions, except that bradykinin 
(RPPGFSPFR) (Sigma Chemical, St Louis, USA) was used to establish standard curves 
(Rollins-Smith et al., 2002b). To avoid problems with proteolysis, all peptide solutions were 
stored at –80ºC.  
 
2.2.2 Protease digestion  
The peptide digests were generated to provide a negative control for studies of the activity of 
the skin peptides. The peptide mixtures (1 mg/ml) were incubated with pronase E, a protease 
mixture that degrade peptides completely (Sigma Chemical, St Louis, USA), at a concentration 
of 0.5 mg/ml in ammonium phosphate buffer (pH 7.0) at 37ºC for 20 h. After digestion, the 
protease was inactivated by heating at 90 ºC for 10 min. 
 
2.2.3 Analyses of skin peptide profiles 
The liquid chromatography mass spectrometry (LC-MS) analyses of the samples of the natural 
peptide mixtures were carried out at Chemistry Department University of Canterbury 
(Christchurch, New Zealand) using Waters 2790 HPLC system. Peptide solutions analysed had 
a concentration of 0.1 mg/ml in ddH20 with 0.1% formic acid. The separation was carried out 
using a Zorbax SB-C18 analytical column (5 µ, 2.1 x 250 mm). Mobile phase A was 0.5 % 
formic acid in ddH2O and mobile phase B was 0.5 % formic acid in acteonitrile. The gradient 
consisted of a 40 minute run, following a solvent gradient comprised of the following steps: 
two minutes at 90% A and 10% B followed by a linear gradient to 25% A and 75% B over a 
period of 12 minutes, an isocratic hold at 25 A% and 75% B for ten minutes then a linear 
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gradient to 100% B over two minutes. 100% B was maintained for four minutes before the 
solvent ratio was returned to 90% A and 10% B in two minutes. The 90% A and 10% B was 
held for eight minutes to allow the column to re-equilibrate. Detection of molecular ions was 
undertaken using the Micromass-LCT-TOF mass spectrometer equipped with an electrospray 
ionisation (ESI) probe. A probe voltage of 3,200 V at 150°C, a source temperature of 80°C, 
nebuliser gas flow of 160 L/hr and desolvation gas flow of 520 L/hr were used.  Samples were 
analysed with a cone voltage of 25 V unless otherwise stated. This system was controlled by 
MASSLYNX (Version 4.0) software. Skin peptides were identified by comparing their 
molecular masses with previously published masses of peptides of X. laevis and three Litoria 
species: L. raniformis, L. aurea, and L. ewingii (Giovannini et al., 1987, Moore et al., 1991, 
Steinborner et al., 1997, Rozek et al., 2000).  
 
The liquid chromatography mass spectrometry/ mass spectrometry (LC-MS/MS) analyses were 
carried at The Centre for Genomics & Proteomics, The University of Auckland (Auckland, 
New Zealand) using the Ultimate LC system (LC Packings/Dionex). The conditions were 
optimised by two LC-MS analyses. Peptide solutions analysed had a concentration of 0.1 
mg/ml in ddH20 with 0.1% formic acid. The separation was carried out using a Zorbax 300SB 
C18 analytical column (0.3mm X 100 mm, StableBond (300Ǻ). Mobile phase A was 0.1 % 
formic acid in ddH2O and mobile phase B was 0.1 % formic acid in acteonitrile. The gradient 
applied was as follows: from 0 to 5 min 95% A and 5% B, from 5 to 59 min 40% A and 60% B, 
from 59 min to 70 min 95% B and 5% A and from 70 to 85 min 95% A and 5% B. Detection of 
molecular ions was undertaken using a QSTAR XL electrospray quadrupole/ time-of-flight 
mass spectrometer (Applied Biosystems, Foster city, CA, USA). The instrument was set to 
perform a TOF-MS scan from 300 to 1800 m/z for 1 second, followed by two products ion 
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scans from 70-1600 m/z (one 1 second, the second 2 seconds) on the two most abundant ion 
species (double and triple charged) using the “Enhance All” feature. The data were acquired 
using Analyst QS software.  
 
The assignment of molecular masses of fragments obtained by peptides fragmentation to the 
primary sequence of the peptides stored in database was carried out by using Mascot search 
engine that include probability based algorithm (http:/www.matrixscience.com, Perkins et al., 
1999). In Mascot, the score for an MS/MS match is based on the absolute probability (P) that 
the observed match between the experimental data and the database sequence is a random 
event. The reported peptide fragment ion's score is –10Log(P), where P is the probability that 
the observed match is random event and peptides scores are derived from ions scores as non-
probabilistic peptide hits. The identities of peptide sequence were determined by using the 
Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1997) at the National Centre for 
Biotechnology Information (NCBI) web site (http:// www.ncbi.nlm.nih.gov). Identification was 
carried out by using the following criteria: non-redundant NCBI protein database, X. laevis and 
other lobe-finned fish and tetrapod clade as taxonomic category, ion score cut at 20, no enzyme 
used, peptide mass tolerance : ± 0.2 Da, fragment mass tolerance: ± 0.1 Da, variable 
modifications including amide (C-term), deamidation (NQ), oxidation (M), pyro-glu (N-term 
Q). Information on peptides fragments provided in appendices A–D. 
 
2.2.4 Bacterial cultures 
All bacterial isolates were obtained from frog pathogen librarium, kept at the School of 
Biological Sciences, University of Canterbury (Christchurch, New Zealand). The collection 
includes different bacterial isolates collected from the hearts of septicemic animals during an 
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extensive epidemiological survey between 2002 and 2006 (Barribeau, 2007). The bacterial 
isolates used for analyses were collected as follows. Isolates of A. hydrophila, C. freundii, P. 
aeruginosa and S. liquefaciens were collected from captive X. laevis in 2003, and the isolate of 
C. meningosepticum was collected from captive L. aurea in 2002. The skin isolate of 
saprophyte Lactococcus lactis was collected from captive L. raniformis in 2004. In addition to 
these isolates, isolates of A. hydrophila, K. pneumoniae and P. mirabilis were collected from L. 
ewingii taken from a site in Oxford Forest, New Zealand, in December 2005 at time of severe 
mortality outbreak. During bacterial isolation, the septicemic animals that were no longer 
bright, alert, and active were euthanized by immersion in a humane euthanizing agent of 3% 
aqueous solution of chloral hydrate, and after that were dissected under aseptic conditions. 
Small pieces of hearts (approx. 0.5 mg) were taken and cultured in tryptone soya broth (TSB, 
Oxoid, Basingstoke, UK). All cultures were incubated aerobically for 24h at 30°C. The broth 
cultures were then plated onto tryptone soya agar (TSA, Oxoid, Basingstoke, UK) and 
incubated under the same conditions. Pure colonies were examined for shape and arrangement 
of cells by Gram staining and identified at phenospecies level using three commercial aerobic 
bacterial identification systems: Microbact 24E (12E/12A + 12B, Medvet diagnostics, 
Thebarton, SA, Australia), RapID CB plus and RapID NF plus (Lenexa, Kansas, USA). After 
identification they were stored on TSA slants at 4 ºC and on cryobeads at –80ºC. The standard 
reference strain Escherichia coli (ATCC25922) was purchased from American Type Culture 
Collection (University Boulevard, Manassas, USA). 
 
2.2.5 Antibacterial assays 
The activities of peptide mixtures were tested using growth inhibition assays for aquatic 
bacteria (Rollins-Smith et al., 2002a). Overnight colonies of each isolate were selected from 
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agar, transferred to soya tryptone broth and incubated for 8 h. Following incubation, the 
bacterial suspension was adjusted with phosphate buffered saline to achieve turbidity of 0.5 
McFarland standard (corresponding to 1.5 x 108 colony forming units (cfu) per ml), and the 
adjusted suspension was used as inoculum. For the growth inhibition assay, 50 µl of Muller-
Hinton broth with a bacterial concentration of 1 x106 cfu was plated into each well of a 96-well 
microtiter plate, and 50 µl of peptide was then added to each well, in serial dilutions (500, 250, 
125, 62.5, 31.2, 15.6, 7.8 and 3.9 µg/ml). The exceptions were non-peptide wells, which 
received 50 µl of peptide digest instead of peptides, positive control wells, which received 50 µl 
of ddH2O instead of peptides, negative controls wells that received 2 µg of the peptide 
antibiotic polymyxin B and negative controls that received 0.4% paraformaldehyde, on separate 
plates. For growth inhibition assays with L. lactis, soya tryptone broth was used instead of 
Muller-Hinton broth. The samples were incubated aerobically for 24 h at 30ºC and bacterial cell 
growth was measured as increased optical density at 490 nm with an ELISA plate reader. Five 
replicate reactions were tested for each peptide concentration and three independent assays 
were performed for all tested peptides. To determine Minimum Inhibitory Concentration 
(MIC), the means of optical density values of the wells with peptide concentrations that 
completely inhibited growth were compared with the optical density values of the positive 
control reactions with no visible growth. The MIC was defined as the lowest concentration at 
which no significant growth was observed as in negative control reactions with 0.4% 
paraformaldehyde. 
 
The same assay was used for testing activities of single peptides. The activities of magainin 2, a 
single peptide of X. laevis (GIGKFLHSAKKFGKAFVGEIMNS) (Sigma Chemical, St Louis, 
USA) and aurein 2.1 a single peptide of L. aurea and L. raniformis 
Chapter 2: Activity of skin peptides against bacterial pathogens 
 31
(GLLDIVKKVVGAFGSL.CO-NH2)(Sigma-Genosys, Castle Hill, NSW, Australia) were 
tested at a concentration range of  200, 100, 50, 25, 12.50, 6.25 and 3.12 µg/ml. The activities 
of two non-amphibian peptides: polymyxin B, a single peptide of Bacillus polymyxa (cyclic 
octapeptide) (Sigma Chemical, St Louis, USA) and cecropin A, a single peptide of insect 
Hyalophora cecropia (KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2) 
(Sigma Chemical, St Louis, USA) at a concentration range of 100, 50, 25, 12.5 6.25, 3.12, 1.56, 
0.78, 039 and 0.19 µg/ml. 
 
2.2.6 Determination of MIC equivalents  
The efficiency of skin peptides of ten animals of each species was measured against the isolate 
of K. pneumoniae. The average amount of recovered peptides per one animal of each Litoria 
species is only sufficient to test activity only against one pathogen. To compare efficiency of 
skin peptides between frog species, mean MIC equivalent per 1 g body mass, and mean MIC 
equivalent per cm2 surface area of each species was calculated. An MIC equivalent is the 
concentration of peptides recovered from each sample after elution from the C-18 Sep-Pak 
cartridges (concentrated to dryness and dissolved in water) adjusted to standard 1 g body mass 
(gbm) or per surface area divided by experimentally determined MIC (µg/ml) for each animal 
(Woodhams et al., 2006). For example, if the total amount of peptides recovered from a 10 g 
animal was 50 µg and MIC was 100 µg/ml, MIC equivalent for that sample of skin secretion 
would be 0.05. The surface area of adult animals for calculation of MIC equivalents was 
calculated using an equation from McClanahan and Baldwin (1969): surface area (cm2) = 9.90 
(mass in grams)0.56. To test for differences among species in total peptides recovered and MIC 
equivalents per gbm (or per surface area) Kruskal-Wallis rank tests were used, and pairwise 
comparisons were made using Mann-Whitney U-tests with an alpha level of 0.016, following 
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Bonferroni’s correction. All analyses were performed with SPSS v. 12 (SPSS Inc. Chicago, 
Illionois, USA).  
2.2.7 Analysis of production and activity of skin peptides in response to low environmental 
temperature  
In order to obtain skin secretions from animals at different environmental temperature 
conditions, two groups of adult animals of L. raniformis were held in two different 
environmental chambers for four weeks in February 2005. One group of animals was held at a 
low environmental temperature (15ºC) while the other group of animals was used as a control 
group and held at optimal environmental temperature (23 ºC). Animals were housed 
individually in Sistema 7L polypropylene box tanks with a snap lid (350 x 200 x 100 mm). The 
lids of the containers had drilled ventilation holes. Each box contained two dry and moistened 
Hygenex paper towels. Paper towels were moistened with aged water and changed weekly. In 
addition to these measures, a shot glass of height 55 mm and diameter 95 mm with water was 
put into each box to provide additional source of water. Skin peptides were collected from each 
animal on the first and last day of the experiment. The quantity of skin peptides recovered and 
their activity against the isolate of K. pneumoniae were measured for each animal. Differences 
between two groups of animals in total recovered peptides, MIC, MIC equivalents per gbm and 
surface area were tested by the nonparametric Mann-Whitney U-tests. 
 
2.3 Results 
2.3.1 Comparison of skin peptide profiles  
Skin peptide profiles obtained by LC-MS were markedly different among species. Molecular 
masses of ten different peptides of X. laevis matched the molecular masses of  previously 
known antimicrobial peptides belonging to four different groups including 1) two magainin 
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peptides (magainin 1, 2); 2) peptide with amino-terminal glycine and carboxyl-terminal 
glutamine (PGQ); 3) four caerulein precursor fragments (CPF 1–4); and 4) three related 
peptides including xenopsin precursor fragment (XPF), levitide precursor fragment (LPF) and 
peptide with amino-terminal glycine and carboxyl-terminal leucinamide (PGLa) (Fig. 2.1A; 
Table 2.1). Similarly, eight molecular masses of L. aurea peptides matched the molecular 
masses of previously described antimicrobial peptides of the aurein peptide family that is 
common to L. aurea and L. raniformis, including aurein 2.1, aurein 2.2, aurein 2.3, aurein 2.4, 
aurein 2.5, aurein 3.1, aurein 3.2 and aurein 5.2 (Fig. 2.1B; Table 2.2), while nine molecular 
masses of peptides of L. raniformis matched the molecular masses of aurein 1.1, aurein 1.2, 
aurein 2.1, aurein 2.5, aurein 2.6, aurein 3.1, aurein 3.2, aurein 3.3 and aurein 5.2 (Fig. 2.1C; 
Table 2.3). A molecular mass of 1427.60 Da of a peptide of L. ewingii corresponded to the 
molecular mass of uperin 7.1, the previously described antimicrobial peptide of this species 
(Fig. 2.1D; Table 2.4). Significant protein hits obtained by LC-MS/MS peptides fragments 
analyses of the natural peptides mixtures of the all four tested species confirmed the amino acid 
sequences of the majority of the species specific antimicrobial peptides (Tables 2.1–2.4). Thus, 
natural mixtures of peptides from all four tested species contained elements matching the 
molecular masses of known antimicrobial peptides. 
 
Peptide digests of all four tested species did not contain the elements matching the molecular 
mass of known antimicrobial peptides (Fig 2.2; Appendices E–H). 
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Fig. 2.1 LC-MS analyses of peptide mixtures of four different frog species. The antimicrobial 
peptides that were previously described are labelled as follows. (A) The antimicrobial peptides of X. 
laevis are two magainin peptides (M 1, 2), peptide with amino-terminal glycine and carboxyl-terminal 
glutamine (PGQ), four caerulein precursor fragments (CPF 1–4), xenopsin precursor fragment (XPF), 
levitide precursor fragment (LPF) and peptide with amino-terminal glycine and carboxyl-terminal 
leucinamide (PGLa). (B) Antimicrobial peptides of L. aurea are aureins (labelled with A followed by 
associated number). (C) Antimicrobial aurein peptides of L. raniformis are labelled as in B. (D) Up 7.1 
denotes uperin 7.1, the antimicrobial peptide of L. ewingii. 
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         Table 2.1 Identification of peptides of X. laevis. 
 
Peptide Relative molecular mass (Da) Sequence 
CPF 1 2614.00 GFGSFLGKALKAALKIGANALGGSPQQ 
CPF 2 2690.38 GFASFLGKALKAALKIGANMLGGTPQQ 
CPF 3 2602.65 GLASLLGKALKAGLKIGTHFLGGAPQQ 
CPF 4 2649.05 GLASFLGKALKAGLKIGAHLLGGAPQQ 
PGLa 1966.16 GMASKAGAIAGKIAKVALKAL-NH2 
LPF 2606.79 GWASKIGQTLGKIAKVGLQGLMQPK 
XPF 2661.38 Not identified 
Magainin 1 2407.50 GIGKFLHSAGKFGKAFVGEIMKS 
Magainin 2 2466.58 GIGKFLHSAKKFGKAFVGEIMNS 
PGQ 2455.32 GVLSNVIGYLKKLGTGALNAVLQ 
 
 
Table 2.2 Identification of peptides of L. aurea. 
 
    Table 2.3 Identification of peptides of L. raniformis. 
 
Peptide Relative molecular mass (Da) Sequence 
Aurein 1.1 1444.48 not identified 
Aurein 1.2 1479.27 GLFDIIKKIAESF-NH2 
Aurein 2.1 1614.53 GLLDIVKKVVGAFGSL-NH2 
Aurein 2.5 1646.49 not identified 
Aurein 2.6 1627.65 GLFDIAKKVIGVIGSL-NH2 
Aurein 3.1 1737.59 GLFDIVKKIAGHIAGSI-NH2 
Aurein 3.2 1767.67 GLFDIVKKIAGHIASSI-NH2 
Aurein 3.3 1793.11 GLFDIVKKIAGHIVSSI-NH2 
Aurein 5.2 2449.73 GLMSSIGKALGGLIVDVLKPKTPAS 
 
 
                   Table 2.4 Identification of peptides of L. ewingii. 
 
 
 
 
 
Peptide  Relative molecular mass (Da) Sequence 
Aurein 2.1 1614.53 not identified 
Aurein 2.2 1613.42 GLFDIVKKVVGALGSL-NH2 
Aurein 2.3 1613.42 GLFDIVKKVVGAIGSL-NH2 
Aurein 2.4 1628.46 GLFDIVKKVVGTIAGL-NH2 
Aurein 2.5 1646.49 GLFDIVKKVVGAFGSL-NH2 
Aurein 3.1 1737.59 GLFDIVKKIAGHIAGSI-NH2 
Aurein 3.2 1767.67 GLFDIVKKIAGHIASSI-NH2 
Aurein 5.2 2449.73 GLMSSIGKALGGLIVDVLKPKTPAS 
Peptide Relative molecular mass (Da Sequence 
Uperin 7.1 1427.60 GWFDVVKHIASAV-NH2 
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Fig. 2.2 LC-MS analyses of peptide digests of X. laevis (A), L. aurea (B), L. raniformis (C) and L. 
ewingii (D). 
 
 
2.3.2 Antibacterial activity 
The peptide mixture of X. laevis inhibited the growth of isolates of C. freundii, C. 
meningosepticum, K. pneumoniae, P. aeruginosa and L. lactis and E. coli (ATCC25922) (Fig. 
2.3A; Table 2.5A). The peptide mixture of L. aurea inhibited the growth of isolates of C. 
freundii, K. pneumoniae, P. aeruginosa and L. lactis and E. coli (ATCC25922) (Fig. 2.3B; 
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Table 2.5A). The peptide mixture of L. raniformis inhibited the growth of the same bacteria as 
L. aurea (Fig. 2.3C; Table 2.5A). The peptide mixture of X. laevis was more potent against the 
isolate of C. freundii, K. pneumoniae and P. aeruginosa than the peptide mixtures of L. aurea 
and L. raniformis as shown by the smaller concentrations of X. laevis peptide mixture required 
to inhibit growth of these isolates (MIC values, Table 2.5A). The peptide mixture of L. ewingii 
did not inhibit the growth of any isolates completely (Figs. 2.3D and 2.6D; Table 2.5A). The 
only notable activity for this peptide mixture was growth inhibition of the isolates of C. freundii 
and E. coli (ATCC25922) at concentration of 500 µg/ml, at the rate of 75.8% and 64.9% 
respectively (Fig. 2.4). None of the tested peptide digests inhibited the growth of any bacteria. 
Two single peptides: magainin 2 and aurein 2.1 also inhibited the growth of the isolate of C. 
freundii, K. pneumoniae, P. aeruginosa, L. lactis and E. coli (ATCC25922) (Fig 2.5C,D; Table 
2.5A). None of the tested peptide mixtures or single peptides inhibited the growth of the two 
isolates of A. hydrophila or the single isolates of P. mirabilis and S. liquefaciens (Figs. 2.6 and 
2.7; Table 2.5A).  
 
Two non-amphibian peptides polymyxin B and cecropin A inhibited the growth of different 
bacteria as follows. Polymyxin B inhibited the growth of two isolates of A. hydrophila and the 
isolate of C. freundii, C. meningosepticum, K. pneumoniae, P. aeruginosa and S. liquefaciens 
(Figs. 2.5A and 2.7A; Table 2.5B). Cecropin A inhibited the growth of two isolates of A. 
hydrophila and the isolate of C. freundii, C. meningosepticum, K. pneumoniae, P. aeruginosa 
and P. mirabilis (Figs. 2.5B and 2.7B; Table 2.5B). Both polymyxin B and cecropin A were not 
active against the isolate of L. lactis (Table 2.5B).  
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Table 2.5A Activities of skin peptides from four frog species: X. laevis, L. aurea, L. raniformis and L. ewingii. Natural peptide mixtures and 
single peptides were tested for growth inhibition of bacterial isolates collected from four frog species: X. laevis (Xl), L. aurea (La), L. raniformis 
(Lr) and L. ewingii (Le). * denotes skin saprophyte and ** denotes standard strain. NA denotes no activity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.5B Activities of non-amphibian peptides. For details see Table 2.5A. 
 
MIC values (µg/ml) Isolate 
Polymyxin B Cecropin A
A. hydrophila Le 3.12 3.12 
A. hydrophila Xl 3.12 3,12 
C. freundii Xl 1.56 1.56 
C. meningosepticum La 25.00 12.50 
E. coli (ATCC25922)** 0.78 0.78 
K. pneumoniae Le 3.12 3.12 
L. lactis Lr* NA NA 
P. aeruginosa Xl 1.56 1.56 
P. mirabilis Le NA 50.00 
S. liquefaciens Xl 12.5 NA 
MIC values of peptide mixtures (µg/ml) MIC values of single peptide (µg/ml)Isolate 
X. laevis  L. aurea  L. raniformis L. ewingii  Magainin 2  Aurein 2.1  
A. hydrophila Xl NA NA NA NA NA NA 
A. hydrophila Le NA NA NA NA NA NA 
C. freundii Xl 31.25 62.50 62.50 NA 50.00 100.00 
C. meningosepticum La 500.00 NA NA NA NA NA 
E. coli (ATCC25922)** 62.50 62.50 125.00 NA 25.00 50.00 
K. pneumoniae Le 125.00 250.00 250.00 NA 50.00 100.00 
L. lactis Lr* 500.00 500.00 500.00 NA 100.00 100.00 
P. aeruginosa Xl 62.50 125.00 125.00 NA 50.00 200.00 
P. mirabilis Le NA NA NA NA NA NA 
S. liquefaciens Xl NA NA NA NA NA NA 
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Fig. 2.3 Growth inhibition of K. pneumoniae by peptide mixture from X. laevis (A), L. aurea (B), L. 
raniformis (C) and L. ewingii (D). 
 
 
 
 
 
Fig. 2.4 Growth inhibition of C. freundii (A) and E. coli (ATCC25922) (B) by peptide mixture from 
L. ewingii . 
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Fig. 2.5 Growth inhibition of K. pneumoniae by polymyxin B (A) cecropin A (B), magainin 2 (C) 
and aurein 2.1 (D). 
 
 
 
 
Fig. 2.6 Growth inhibition of A hydrophila  by peptide mixture from X. laevis (A), L. aurea (B), L. 
raniformis (C) and L. ewingii (D). 
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Fig. 2.7 Growth inhibition of A. hydrophila by polymyxin B (A) cecropin A (B), magainin 2 (C) and 
aurein 2.1 (D). 
 
 
 
2.3.3 Production and efficiency of skin peptides 
Among the four tested species, significant differences were found in the total amount of 
recovered peptide (Kruskal-Wallis rank test, X23 = 33.57, P < 0.05; Table 2.6), Minimum 
Inhibitory Concentrations of peptides necessary to completely inhibit growth of K. pneumoniae 
(MIC (µg/ml); Kruskal-Wallis rank test, X23 = 24.08, P < 0.05; Table 2.6), and in the amount of 
peptide active against K. pneumoniae on the surface area of the skin (MIC equivalents per gbm 
and per cm2; Kruskal-Wallis rank test, X23 = 21.68, P < 0.05 and Kruskal-Wallis rank test, X23  
= 21.53, P < 0.05 respectively; Fig. 2.8; Table 2.6). X. laevis produced the most copious peptide 
secretion, as the average amount of peptide per gram body mass (946.89 µg/1 gbm; Table 2.6) 
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was significantly higher than for the three Litoria species (Mann-Whitney U-test in all pair wise 
comparisons was significant, after Bonferroni’s correction: Z = –3.78, N = 20, P < 0.016; Z 
statistics were identical in each test because the rank order used for their calculation did not 
change in the different tests; one species always occupied the highest half of the rank scores; 
Table 2.6). The peptide mixtures produced by X. laevis were more potent against K. 
pneumoniae than the peptide mixtures of L. aurea and L. raniformis, as shown by the 
significantly lower average minimum inhibitory concentration (MIC) of X. laevis (average MIC 
= 118.75 µg/ml; Table 2.6) compared with L. aurea (Mann-Whitney U-test, Z = –3.88, N = 20, 
P < 0.016; Table 2.6) and L. raniformis (Mann-Whitney U-test , Z = –4.18, N = 20, P < 0.016; 
Table 6). The peptide mixtures produced by L. ewingii were inactive (Table 2.6). A comparison 
of MIC equivalents demonstrated that X. laevis had more available active peptides per gbm and 
per cm2 than L. aurea and L. raniformis (Mann-Whitney U-test in all pair wise comparisons 
were Z = –3.78, N = 20, P < 0.016; Fig. 2.8; Table 2.6). None of the peptide digests obtained by 
proteolysis of skin peptides inhibited bacterial growth. 
 
2.3.4 Effects of temperature on production and activity of skin peptides 
Before cold treatment, no difference was found between the experimental and control groups of 
L. raniformis with respect to the following variables: the average total amount of recovered 
peptide (Mann-Whitney U-test, Z = – 0.58, N = 14, P = 0.620; Table 2.7), the MIC of peptide 
mixtures against K. pneumoniae (Mann-Whitney U- test, Z = 0.99, N = 14, P = 1.000; Table 
2.7), MIC equivalents per gbm (Mann-Whitney U-test, Z = – 0.19, N= 14, P = 0.902; Table 2.7) 
and MIC equivalents per cm2 (Mann-Whitney U-test , Z = –0.48, N= 14 P = 0.710; Table 2.7). 
After cold treatment, the average total amount of recovered peptide and the MIC equivalents 
per gbm and per cm2 for the experimental group were smaller than for the control group (Mann-
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Whitney U-test, Z = –2.75, N = 14, P < 0.05 for total recovered peptides, Z = –2.49, N = 14, P 
< 0.05 in pairwise comparisons of both MIC equivalents; Fig. 2.9; Table 2.7) while the average 
MIC of peptide mixtures against K. pneumoniae was not different (Mann-Whitney U-test, Z = 
0.63, N = 14, P = 710; Table 2.7). None of the peptide digests obtained by proteolysis of skin 
peptides inhibited bacterial growth. 
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         Table 2.6 Production of skin peptides by four different species and efficiency against K. pneumoniae.  
 
 
 
      
 
   Table 2.7 Production of skin peptides of L. raniformis maintained at 15ºC and efficiency against K. pneumoniae.  
 
 
Species  N animals Total peptides per  
1gbm +/-SD 
Average MIC ( µg/ml))+/-
SD  
MIC equivalents per 
1gbm +/-SD 
MIC equivalents 
per surface area 
(cm2)+/-SD 
X. laevis 10 946.89 +/- 113.96 118.75 +/- 19.76 8.533 +/- 3.780 6.625 +/- 3.597 
L. aurea 10 76.32 +/- 6.08 237.50 +/- 39.53 0.336 +/- 0.103 0.160 +/- 0.045 
L. raniformis 10 67.90 +/- 7.05 275.00 +/- 79.06 0.272 +/- 0.028 0.141 +/- 0.006 
L. ewingii 10 117.40 +/- 21.20 No activity 0.000+/- 0.000 0.000 +/- 0.000 
Group  N animals Total 
peptides 
per  1gbm 
+/-SD 
before 
treatment  
Total 
peptides 
per  1gbm 
+/-SD 
after 
treatment 
MIC 
(µg/ml))+/-
SD before 
treatment 
MIC 
(µg/ml))+/-
SD after 
treatment  
MIC 
equivalents 
per 1gbm +/-
SD before 
treatment  
MIC 
equivalents 
per 1gbm 
+/-SD 
after 
treatment 
MIC 
equivalents 
per cm2 
surface area  
+/-SD before 
treatment  
MIC 
equivalents 
per cm2 
surface 
area +/-SD 
after 
treatment 
Treatment  7 75.45 +/- 
9.51 
57.15 +/- 
6.59 
232.14 +/- 
47.25 
232.14 +/- 
47.25 
0.347 +/-  
0.133 
0.260+/- 
0.083 
0.176 +/- 
0.069 
0.131 +/- 
0.043 
Control  7 73.59 +/- 
7.70 
68.29 +/- 
5.15 
232.14 +/- 
47.25 
214 +/- 
60.99 
0.330 +/-  
0.099 
0.346+/- 
0.113 
0.180 +/- 
0.062 
0.188 +/- 
0.076 
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Fig. 2.8 Comparison of MIC equivalents of four different species. If value bar is not shown, the 
value is equal to 0.  
 
 
 
 
 
Fig. 2.9 Comparison of MIC equivalents of two groups of L. raniformis held at two different 
environmental temperatures.  
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2.4 Discussion 
The results show that peptide defences might provide direct protection from some 
opportunistic bacterial pathogens associated with bacterial dermatosepticemia. Most 
importantly, it was observed that natural peptide mixtures and single peptides of three species 
including X. laevis and two Litoria species, L. aurea and L. raniformis, inhibited the growth of 
three different pathogens including C. freundii, K. pneumoniae and P. aerugionsa, and the 
peptide mixture of X. laevis also inhibited the growth of C. meningosepticum (Figs. 2.3A,C and 
2.5C,D; Table 2.5A). Thus, the skin peptides of three species had activities against certain 
bacterial pathogens in vitro, and they might be expected to provide significant protection in 
vivo.  
 
2.4.1 Interspecies variations in activities of skin peptides  
The significance of skin peptide activities in protection of amphibians from different bacterial 
pathogens may depend on a number of factors. It appears that the aquatic species X. laevis 
might have more efficient immune defences in the terms of production and activity of skin 
peptides than the three terrestrial Litoria species. X. laevis produced a significantly greater 
amount of active skin peptide on the skin surface than L. aurea or L. raniformis, while L. 
ewingii did not have active peptides (Fig. 2.8; Table 2.6). Similarly, the peptide mixture of X. 
laevis was able to inhibit growth of several bacteria to a greater extent than the peptide 
mixtures of the three tested Litoria species (Fig. 2.3A,D; Table 2.5A). The greater efficiency of 
the X. laevis peptide mixture could have been due, at least in part, to its greater diversity 
compared with those of the three Litoria species, as observed by LC-MS analyses (Fig. 2.1). 
The potential importance of peptide diversity is supported by the fact that L. ewingii, whose 
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skin peptide mixture did not have activity against bacterial pathogens (Figs. 2.3D and 2.6D; 
Table 2.5A), has the smallest diversity of skin peptides (Fig. 2.1; Table 2.4) and is more 
susceptible to disease than the other Litoria species L. raniformis in my study region (Jenkins, 
2004, Schadich, unpubl. data). Peptide diversification could therefore also be an adaptation 
mechanism to opportunistic bacteria in some habitats.  
 
2.4.2 Resistance of A. hydrophila, P. mirabilis and S. liquefaciens to skin peptides 
Three different pathogens, A. hydrophila, P. mirabilis and S. liquefaciens, were resistant to 
natural mixtures of skin peptides from all four frog species, showing that skin peptides cannot 
provide protection against all pathogens (Figs. 2.6 and 2.7; Table 2.5A). Some animal and 
human isolates of these pathogens have ability to develop resistance to different kinds of 
antimicrobial peptides by secretion of proteases or by modification of the polysaccharide 
components of their outer membrane (Storm et al., 1977, Smeianov et al., 2000, McCoy et al., 
2001, Rosenfeld et al., 2006). Aeromonas, Proteus and Serratia spp. are normal components of 
skin microbiota of healthy frogs (Hird et al., 1981), so resistance to skin peptides may have co-
evolved with their host (Boman 2000, Woodhams et al., 2007). The symbiotic bacterial species 
that are present on skin might be regulated by microbial antagonism, as some bacterial species 
have been shown to inhibit the growth of other bacterial species by chemical or competitive 
means (Pearson 1998, Woodhams et al., 2007). This regulation may be disrupted by stress 
associated with seasonal changes in environmental conditions, pollution and crowding, all of 
which could favour bacterial growth, including growth resulting from over-stimulation of 
secretion of skin peptides and consequent removal of antagonistic bacteria (Hazen, 1979, 
Harris et al., 2006, Ashcroft et al., 2007, Ryu et al., 2008). Systematic dissemination of 
bacteria that may pass through the skin may still be prevented by the innate immune system, 
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including macrophages in the skin, lymphatic sinuses and spleen which have a high capacity to 
eliminate pathogens (Pearson, 1998, Taylor et al., 2001, Hayes et al., 2006). Thus, disease 
development caused by A. hydrophila, P. mirabilis and S. liquefaciens may be associated with 
host-pathogen relations that are influenced by regulatory mechanisms other than skin peptides. 
These mechanisms could include microbial antagonism in skin microbiota and macrophages of 
the innate immune system. 
 
2.4.3 Effects of temperature on production and activity of skin peptides 
Production of skin peptides by L. raniformis was significantly reduced at low temperature (Fig 
2.9; Table 2.7). Some environmental factors have been shown to inhibit synthesis and release 
of skin peptides (Rollins-Smith et al., 2002b). Specifically, in response to changes in 
environmental conditions and anthropogenic stressors, frogs and other amphibians produce 
corticosteroid hormones which can have an immunosuppressant effect including inhibition of 
skin peptide production (Simmaco et al., 1998, Carey et al., 1999). Synthesis and release of 
skin peptides by the hibernating wood frog, Rana sylvatica, were completely inhibited by 
lowering environmental temperature to 5 ºC (Matutte et al., 2000). Thus, seasonal 
susceptibility to disease might be a consequence of environmental conditions affecting skin 
defences and pathogen virulence (Hazen, 1979, Taylor et al. 2001). Future studies should focus 
on the possible influence on the immune response of other environmental factors including pH, 
ultra-violet radiation and pollutants. 
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Chapter 3: Comparison of Skin Peptides of Tadpoles, Metamorphs 
and Adults of L. ewingii 
 
3.1 Introduction 
In frogs, granular glands of skin dermis are important in innate immune defences. They are the 
site of synthesis and storage of antimicrobial peptides (Bevins and Zasloff, 1990, Erspamer, 
1994). Following injury or microbial challenge, these peptides are secreted onto skin surface to 
provide protection from invading microbial pathogens (Simmaco et al., 1998, Rollins-Smith et 
al., 2005, Woodhams et al., 2007). 
 
The granular glands are fully developed only after metamorphosis, a transition period from 
tadpole (larvae) to adult animal (Delfino, 1991, Viertel and Richter, 1999) which might suggest 
the innate defences of tadpoles not be fully developed. Moreover it is known that the adaptive 
immune defences of tadpoles that include responses specific to pathogens are impaired (Flajnik 
et al., 1986, Flajnik et al., 1987, Pross and Rowlands, 2005). These facts raise the question of 
how the skin of tadpoles is protected from invading microbial pathogens prior to 
metamorphosis.  
 
Immediately after metamorphosis the adaptive immune defences of newly metamorphed 
animals are suppressed by high blood levels of corticosteroids associated with metamorphic 
events (Rollins-Smith, 1998). Secretion of skin peptides from granular glands can also be 
affected by corticosteroids and therefore the skin defences of metamorphs could be suppressed 
(Simmaco et al., 1998).
Chapter 3: Comparison of skin peptides of tadpoles, metamorphs and adults of L. ewingii 
 
 57
Some experimental studies have shown that small serous epidermal glands of tadpoles could 
secrete peptides (Liem, 1961, Richards, 1992, Delfino, 1991, Delfino et al., 2007). Wabtntiz et 
al. (1998) demonstrated the synthesis of peptides of tadpoles of the Magnificent Tree Frog 
(Litoria splendida) in skin starts well before the onset of metamorphosis. Woodhams (2003) 
collected skin secretions from tadpoles for studies with chytrid fungi but did not analyse them 
chemically.  
 
Secretion of skin peptides may depend on the life stage of the frogs. The aim of this study was 
to determine how antibacterial activity of skin peptides differs with the three different life 
stages: tadpoles, metamorphs and adults. Peptides were collected from tadpoles and 
metamorphs of L. ewingii and tested for activity. 
 
3.2 Material and Methods 
3.2.1 Rearing tadpoles and metamorphs 
Animals used in this study were collected as recently hatched tadpoles at a pond in Oxford 
Forest, Canterbury in August 2007 and raised until completion of metamorphosis in a 
vivarium. Their developmental stages were determined using the Anstis 46-stage 
developmental chronology (Anstis, 2002). A photograph shows animals at two different 
developmental stages (Fig. 3.1). The tadpoles were kept in propylene tanks (340 x 290 x 180 
mm) and progressively thinned to a final density of 1 tadpole/l of pond water to attenuate the 
negative impact of growth inhibitors emitted by fast-growing individuals. Their daily diet 
consisted of frozen endive fragments ad libitum once daily and Wardley's “Small fry” liquid 
food once per week as a protein supplement. At metamorphosis, the water levels of tanks were 
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reduced to 1 cm and changed weekly. After metamorphosis, metamorphs were fed adult 
vinegar flies, Drosophila melanogaster, three times per week. The water source both for 
tadpoles and metamorphs was municipal water that was aged, non-chlorinated and filtered. 
Two adult animals were obtained from the captive colony of L. ewingii kept in the vivarium. 
 
 
Fig. 3.1 Tadpole at stage 41 (A) and metamorph at stage 46 (B).  
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3.2.2 Induction, collection and purification of skin peptides  
Skin peptides were induced and collected from ten tadpoles (stage 41), ten metamorphs (stage 
46) and two adults by the same procedure as described in section 2.2.1 with two exceptions. 
The first exception was that the dosage of norepinephrine was reduced to 1 nmol per 1 g of 
body mass in order to avoid negative effects of norepinephrine on tadpoles and metamorphs. 
The second exception was the tadpoles were dosed with norepinephrine by intramuscular 
injections into the dorsal tail muscle due to absence of a developed dermis while adults and 
metamorphs were dosed with norepinephrine as described in section 2.2.1. Purification and 
quantification of skin peptides was carried out as described in section 2.2.1. To obtain 
sufficient material for analyses, the peptide samples were pooled.  
 
3.2.3 Protease digestion 
Peptide digest of adults and metamorphs were obtained by digestion of peptides with Pronase 
E. Peptide digests of tadpoles were not obtained due to limited amount of recovered peptides. 
The procedure for peptide digestion was as described in section 2.2.2. 
 
3.2.4 Analyses of antibacterial activity of skin peptides of tadpoles and metamorphs 
The activity of peptide mixtures was measured against easily manipulated Escherichia coli 
(ATCC25922) as an indicator organism by growth inhibition assay as described in section 
2.2.5 except that only peptide concentration of 500 µg/ml was tested because of limited peptide 
amounts. Five replicate reactions were tested for each peptide sample and two independent 
assays were performed. Growth inhibition was calculated using the following formula 
((positive control optical density – sample optical density)/(positive control optical density)) X 
100 and expressed as a percentage. 
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3.2.5 LC-MS analyses of skin peptides  
LC-MS analysis of peptide mixtures was performed as described in section 2.2.3. 
 
3.3 Results 
3.3.1 Negative effects of peptide collection 
Three tadpoles died within one hour after collection of skin peptides. The other tadpoles and all 
of the metamorphs and adults remained healthy without any sign of change in behaviour.  
 
3.3.2 Amount of collected peptides  
The amounts of recovered peptides of tadpoles, metamorphs and adults were 431, 761 and 688 
µg respectively.  
 
3.3.3 Skin peptide profiles of tadpoles, metamorphs and adults  
Skin peptide profiles obtained by LC-MS were markedly different between tadpoles, 
metamorphs and adults. A molecular mass of 1427.60 Da of a peptide from adults and 
metamorphs corresponds to that of uperin 7.1, the species-specific antimicrobial peptide (Fig. 
3.2B,C; Table 3). The molecular masses of the peptides from tadpoles do not respond to the 
molecular mass of any known frog antimicrobial peptide (Fig. 3.2A; Table 3). Peptide digests 
of adults and metamorphs did not contain elements matching the molecular mass of any known 
antimicrobial peptides (Fig 3.3; Appendix I). 
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Fig. 3.2 LC-MS analyses of peptide mixtures of tadpoles (A), metamorphs (B) and adults (C) of L. 
ewingii. The numbers denotes peaks with peptides and the superscript Up 7.1 associated with the 
number denotes the peak with species-specific antimicrobial peptide uperin 7.1. * denotes peaks with 
non-peptide compounds. 
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             Table 3 Molecular masses of peptides of tadpoles, metamorphs and adults of L. ewingii.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3 LC-MS analyses of peptide digests of adults (A) and  metamorphs (B) of L. ewingii. The 
numbers denote peaks with peptides and * denotes peaks with non-peptide compounds 
 
 
 
 
 
Life stage 
 
Tadpoles Metamorphs Adults 
LC-MS Peak Relative 
molecular 
mass (Da) 
LC-MS Peak Relative 
molecular 
mass (Da) 
LC-MS Peak Relative 
molecular 
mass (Da) 
1 504.84 1 1863.93 1 703.20 
2 781.30 2 703.20 
3 506.88 3 1242.62 
2 979.38 
1176.60 
4 1814.22 4 1176.60 3 1177.76 
  5 1468.92 4 1225.59 
  6 1427.60 5 1185.63 
6 1427.60   7 961.66 
1695.26 7 817.88 
  8 1924.32 8 1456.10 
  9 1721.43 9 1456.10 
  10 1736.37 10 1454.12 
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3.3.4 Activity of skin peptides of tadpoles, metamorphs and adults 
The peptide mixture of tadpoles did not inhibit the growth of E. coli (ATCC25922) (Fig. 3.4). 
The peptide mixtures of adults and metamorphs inhibited the growth of E. coli (ATCC25922) 
by 82.7 and 71.5% respectively (Fig. 3.4). The peptide digests of adults and metamorphs did 
not inhibit the growth of E. coli (ATCC25922) (Fig. 3.4).  
 
 
 
Fig. 3.4. Growth inhibition of E. coli (ATCC25922) by peptide mixtures of tadpoles, metamorphs 
and adults of L. ewingii.  
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3.4 Discussion 
Analyses of antibacterial activity of skin secretions of frogs at three different stages of their life 
history: tadpoles, metamorphs and adults showed that this aspect of their innate immune 
defences is present in postmetamorphic animals, metamorphs and adults but not in tadpoles. 
The peptide mixture of metamorphs and adults had notable activity against E. coli 
(ATCC25922) while the peptide mixture of tadpoles was inactive (Fig. 3.4). These differences 
correlated with differences in peptide profiles, since the peptide mixtures of metamorphs and 
adults had the species-specific antimicrobial peptide present (Fig. 3.2B,C; Table 3) while that 
of tadpoles did not possess any antimicrobial peptide (Fig. 3.2A; Table 3) which is consistent 
with the absence of granular glands in tadpoles (Delfino, 1991). 
 
Skin peptides were collected from tadpoles that have small serous epidermal glands (Fig. 3.2A; 
Table 3) providing evidence of a secretory mechanism exclusive of granular glands. The 
physiological role of these peptides is not known, but could include chemical cues to 
conspecifics (Fox, 1988). Since skin secretions are conserved physiological mechanisms 
(Erspamer, 1994), these observations on skin peptides of tadpoles of L. ewingii suggest 
avenues for future research on the role of skin peptides in tadpoles.  
 
The skin innate defences of tadpoles do not appear to include antimicrobial peptides as 
indicated by absence of activity against E. coli (ATCC25922) (Figs. 3.2A and 3.4) although it 
is possible there might be extreme specificity with pathogenic bacterial strains. An innate 
defence that is efficient includes isolation and sequestration of pathogens by a well developed 
system of macrophages (Ishii et al., 2007), and this mechanism might be essential in protection 
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against pathogens. In addition, resistance of tadpoles to some pathogens could depend on 
presence or absence of specific skin structure such as the absence of keratinised stratum 
corneum in epidermis which confers resistance to the frog chytrid fungus (Batrachochytrium 
dendrobatidis) associated with disease (Berger et al., 1999). 
 
The observation that skin peptides from metamorphs had antibacterial activity (Figs. 3.2B,C 
and 3.4) suggests a role of skin peptides in adaptation to microbes of changed habitat. 
Metamorphs encounter many new potential pathogens as they switch from an aquatic to a dual 
habitat that includes both aquatic and terrestrial habitation (Alford, 1999). The only efficient 
immune defence that includes macrophages is suppressed due to the high blood level of 
corticosteroids associated with metamorphic events (Rollins-Smith, 1998). Furthermore due to 
keratinisation of stratum corneum of epidermis, susceptibility to disease increases (Berger et 
al., 1999). Thus, secretion of skin peptides could be essential in protection of metamorphs 
against pathogens. Further studies should focus on activity of skin peptides of metamorphs 
against frog-specific pathogens. 
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Chapter 4. Protease Mediated Inactivation of Skin Peptides  
 
4.1 Introduction 
The bacterium Aeromonas hydrophila and some other Gram-negative bacterial species 
including Chryseobacterium indologenes, Chryseobacterium meningosepticum, Citrobacter 
freundii, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Serratia 
liquefaciens have been associated with bacterial dermatosepticemia, a fatal infectious disease 
of frogs (Glorioso et al., 1974, Nyman, 1986, Taylor et al., 2001, Mauel et al., 2002). They are 
opportunistic pathogens that are normally found in the skin and gut microbiota of healthy frogs 
but are known to cause disease in animals with compromised immune defences (Hird et al., 
1981, Carey and Bryant, 1995, Taylor et al., 2001, Hayes et al., 2006).  
 
Virulence of these bacteria depends on the elaboration of various biologically active 
extracellular products (ECPs) (Rigney et al., 1978, Pearson, 1998, Pearson et al., 2000). 
Rigney et al. (1978) have demonstrated that bacterial ECPs with haemolytic activity are 
associated with extreme oedema, haemorrhage and tissue necrosis in many organs while 
Pearson (1998) showed that proteases are associated with tissue invasion by bacteria and 
suggested that because of their ability to degrade different protein components these bacteria 
might inhibit certain immune mechanisms.  
 
The only effective immune defence of frog skin against invading pathogens is the antimicrobial 
peptides of the innate immune system. Inhibition of these peptides by the ECPs could enable 
pathogens to evade elimination (Simmaco et al., 1998, Rollins-Smith et al., 2002, Rollins-
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Smith et., al 2005, Woodhams et al., 2007). Evidence for a role of proteolytic ECPs in the 
resistance of bacteria to skin peptides has been found in this study. It was shown that the 
bacterium most frequently isolated from diseased frogs, A. hydrophila, is resistant to skin 
peptides of four different frog species including African Clawed Frogs (Xenopus laevis) and 
three Australian Litoria species: L. aurea, L. raniformis and L. ewingii. Three other pathogens, 
C. freundii, K. pneumoniae and P. aeruginosa were susceptible to the skin peptides of three of 
these species X. laevis, L. aurea and L. raniformis (Rollins-Smith et al., 2002; described in 
Chapter two). To date the resistance mechanisms of frog bacterial pathogens to skin peptides 
have not been studied.  
 
The aim of this study was to determine whether the bacterial ECPs with protease activity can 
modulate the action of skin peptides. ECPs from A. hydrophila and K. pneumoniae were tested 
against skin peptides of three frog different species: X. laevis, L. aurea and L. raniformis.  
 
4.2 Materials and Methods 
4.2.1 Bacterial cultures  
Isolates of A. hydrophila and K. pneumoniae collected from wild L. ewingii were accessed  
from the U. C School of Biological Sciences collection of frog bacterial isolates as  
described in section 2.2.4. 
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4.2.2 Peptide solutions  
Peptide mixtures of X. laevis, L. aurea and L. raniformis, two single peptides magainin 2 from 
X. laevis and aurein 2.1 from L. aurea and L. raniformis respectively and polymyxin B were 
prepared from stock solutions as described in section 2.2.1. 
 
4.2.3 Growing bacterial cultures, production and preparation of extracellular products 
(ECPs) 
Bacterial isolates were grown in 18 h shake culture in 50 ml of tryptone soya broth (TSB, 
Oxoid, Basingstoke, UK) in 100 ml Erlenmeyer flasks at 30ºC. 100 µl of this bacterial broth 
were inoculated into 250 ml of tryptone soya broth in 500 ml Erlenmeyer flasks and incubated 
as above for 36 h. Samples were removed at 0 h, 8 h, 16 h, 24 h and 36 h and examined for 
bacterial growth by determining the optical density at 610 nm. The bacterial suspension was 
then centrifuged at 10, 000 g for 20 min at 4ºC, and the supernatant filter sterilized using a 0.22 
µm Millipore membrane filter. The cell free supernatant was used as a source of the ECPs. 
Three independent experiments were performed for each bacterial isolate. 
 
4.2.4 Protease detection on agar media 
Proteases produced by bacterial cells growing on Mueller-Hinton agar containing 10% (w/v) 
skimmed milk were assessed as described by Castro-Escarpulli et al. (2003). The bacterial 
broth that was used as inoculum was spread to the point of attaining single colonies and 
incubated at 30 ºC for 24h. The presence of a clear zone around the colonies indicated protease 
activity.  
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4.2.5 Protease activity of ECPs  
Proteolytic activity of ECPs from each culture was determined as described by Khalil and 
Mansour (1997). Casein 1% (w/v) dissolved at in 0.1 M glycine-sodium hydroxide buffer (pH 
9.6) was used as the substrate solution. One milliliter of ECP was added to 1ml substrate 
solution and incubated at 30ºC for 10 min. The reaction was stopped by adding 0.1ml of 1M 
trichloroacetic acid and left to stand for several minutes. The resultant precipitate was removed 
by centrifuging at 6, 000 g for 10 min at 4ºC. The absorbance of supernatant fluid was 
measured at 280 nm. In control reactions trichloroacetic acid was added at zero time. One unit 
of proteolytic activity was expressed as an increase of 0.01 in the absorbance value at 280 nm. 
 
4.2.6 Protease Inhibitor Treatment 
The ECPs of each culture were incubated at 30ºC for 1 h with the three different protease 
inhibitors, phenyl methyl sulfonyl fluoride (PMSF; 1 mM), ethylene diamine tetra-acetic acid 
(EDTA; 2 mM) and leupeptin (0.1 mM), which are specific for proteases of Aeromonas 
species. 
 
4.2.7 Effects of temperature on protease activity of ECPs 
The stability of proteases at elevated temperature was measured by heating 300 µl of the ECP 
of each culture to 90 ºC for 15 minutes. After heat treatment, the protease activity was 
measured as described above.  
 
4.2.8 Inhibition of skin peptide activity by ECPs 
The ability of the ECPs to inhibit the activity of peptide mixtures and single peptides was 
determined by bio-assay as described by Devine et al. (1999). 150 µl solutions of peptides at a 
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concentration of 300 µg/ml in ddH2O were incubated with 150 µl of ECPs or ECPs that had 
been heat inactivated at 30 ºC for 1 h. Control reactions included only 150 µl soya tryptone 
broth. Following incubation, 50 µl of each peptide/ECP mixture were transferred to 96 well 
micro-titer plates. Their activity against the easily manipulated Escherichia coli (ATCC25922) 
bacterium were tested by growth inhibition assay as described in section 2.2.5. 
 
4.3 Results 
4.3.1 Secretion of proteases on agar media 
A. hydrophila was shown to produce protease as indicated by clear zones around colonies (Fig. 
4.1A) while no protease activity was detected for K. pneumoniae (Fig. 4.1B).  
 
4.3.2 Protease activity of ECPs  
The presence of protease activity in the ECPs of A. hydrophila was dependent on the 
incubation time of the cultures (Fig. 4.2A). No activity was detected in the ECPs from 0 h and 
8 h cultures, while the activity of the ECPs from the 16 h, 24 h and 36 h cultures increased with 
incubation time of the cultures (Fig. 4.2A). The activity was lost upon treatment with protease 
inhibitors. No protease activity was detected in the ECPs of K. pneumoniae (Fig. 4.2B). Heat 
treated ECPs of both bacterial cultures did not show protease activity (Fig. 4.2). 
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Fig. 4.1 Analysis of protease activity of the ECPs of A. hydrophila (A) and K. pneumoniae (B) on 
skim milk-agar media
  75
 
 
Fig. 4.2 Cell growth and protease activity of ECPs of A. hydrophila (A) and K. pneumoniae (B) cultures at different incubation time. 
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4.3.3 ECP mediated inhibition of activity of skin peptides  
A. hydrophila ECPs were shown to inhibit the single peptides and peptide mixtures from 
X. laevis, L. aurea and L. raniformis (Figs. 4.3 and 4.4). The activity was dependent upon 
the incubation time of A. hydrophila in culture. Activity was only found in cultures 
grown for 16 h and longer (Figs. 4.3 and 4.4). It is interesting to note that A. hydrophila 
ECPs did not affect the activity of polymyxin B (Fig. 4.4); however, polymyxin B has 
disulfide bonds in its structure which may confer greater stability to proteases as shown 
by Paulus and Gray (1964). The ECPs of K. pneumoniae which were not proteolytic in 
nature had no effect on the frog peptides (Figs. 4.5 and 4.6). Heat treatment of ECPs 
abolished any inhibitory effects on the skin peptides (Figs. 4.3–4.6).  
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Fig. 4.3 Activity of peptide mixtures of X. laevis, L. aurea and L. raniformis against E. coli 
(ATCC25922) after treatment of the peptides with ECPs from A. hydrophila cultures grown 
for 0 h (A), 8 h (B), 16 h (C), 24 h (D) and 36 h (E). 
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Fig. 4.4 Activity of polymyxin B, magainin 2 and aurein 2.1 against E. coli (ATCC25922) 
after treatment of the peptides with ECPs from A. hydrophila cultures grown for 0 h (A), 8 h 
(B), 16 h (C), 24 h (D) and 36 h (E). 
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Fig. 4.5 Activity of peptide mixtures of X. laevis, L. aurea and L. raniformis against E. coli 
(ATCC25922) after treatment of the peptides with ECPs from K. pneumoniae cultures 
grown for 0 h (A), 8 h (B), 16 h (C), 24 h (D) and 36 h (E). 
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Fig. 4.6 Activity of polymyxin B, magainin 2 and aurein 2.1 against E. coli (ATCC25922) 
after treatment of the peptides with ECPs from K. pneumoniae cultures grown for 0 h (A), 8 
h (B), 16 h (C), 24 h (D) and 36 h (E). 
 
 
 
4.4 Discussion 
The ECPs of A. hydrophila, which are proteolytic in nature, appear to be responsible for 
the resistance of this bacterium to the skin peptides of three frog species X. laevis, L. 
aurea and L. raniformis. Significantly, the ECPs of A. hydrophila, a pathogen resistant to 
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peptide mixtures and single peptides of all three frog species, completely inhibited the 
activity against E. coli (ATCC25922) of the peptides of these frog species (Figs. 4.3 and 
4.4), The ECPs were inhibited by heat treatment (Fig. 4.2A). Moreover, the ECPs of K. 
pneumoniae, a pathogen susceptible to peptide mixtures and single peptides of all three 
species, did not have protease activity and did not inhibit the activity of the frog skin 
peptides against E. coli (ATCC25922) of peptide mixtures or single peptides of all three 
species (Figs. 4.1, 4.2B, 4.5, 4.6). The virulence of A. hydrophila would, therefore, 
appear to be associated with the production of proteases and this is consistent with the 
hypothesis of Pearson (1998) that A. hydrophila could have mechanisms to evade 
destruction by immune defences and thereby ensure a sufficient number of bacterial cells 
required for tissue invasion in the initial phase of disease. 
 
It is also possible proteases provide better acquisition of nutrients in infected tissues as 
suggested by the degradation of skim milk proteins (Fig. 4.1A) and promote bacterial 
invasion of tissues. Furthermore, it is possible that after bacterial entry into blood and 
lymph, proteases could inhibit innate immune defence mechanisms involving 
macrophages and natural killer cells by degrading cytokines. These proteins are required 
for activation of these cells, and thereby ensure systematic dissemination of pathogen.  
 
A. hydrophila is commonly found in diseased animals of many different frog species 
(Hird et al., 1981, Taylor et al., 2001), which might suggest that production of proteases 
evolved initially as a trait required for adaptation to the skin of their host. This suggestion 
is supported by the fact that protease-mediated resistance to skin peptides could enable A. 
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hydrophila to survive on the skin. These proteases might be specific to host peptides as 
the inhibition of the activity of polymyxin B, a non-frog antimicrobial peptide, was not 
seen (Fig. 4.4).  
 
Although proteases of A. hydrophila could be associated with resistance of the bacterium 
to skin peptides (Figs. 4.3 and 4.4), other mechanisms may be also in place. Some animal 
and human isolates of Aeromonas, Proteus and Serratia spp. also have the ability to 
develop resistance to different kinds of antimicrobial peptides by modification of 
lipopolysaccharide (LPS) and protein components in their outer membranes (Storm et al., 
1977, Smeianov et al., 2000, McCoy et al., 2001, Rosenfeld et al., 2006). Therefore 
future studies on resistance of pathogens to skin peptides should address this issue.  
 
Although resistance mechanisms of opportunistic bacteria to skin peptides might be 
species specific, variations in these mechanisms might occur among different isolates. 
One direction of future research would be to compare resistance to skin peptides among 
different isolates and different species. 
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Chapter 5: Bath Challenges with Bacterial Isolates from Wild 
Frogs  
 
5.1. Introduction 
Bacterial dermatosepticemia is a common disease of frogs. Its epizootic forms are 
associated with mass mortalities in wild populations (Nyman, 1986, Bradford, 1991) and 
significant losses in captive populations (Olson et al., 1992, Taylor et al., 1993, Green et 
al., 1999).  
 
Different opportunistic Gram-negative bacterial species have been isolated from diseased 
frogs including Aeromonas hydrophila, Chryseobacterium indologenes, 
Chryseobacterium meningosepticum, Citrobacter freundii, Klebsiella pneumoniae, 
Proteus mirabilis, Pseudomonas aeruginosa and Serratia liquefaciens (Hunsaker and 
Potter, 1960, Glorioso et al., 1974, Taylor et al., 2001, Mauel et al., 2002). These 
bacterial species can be found amongst the microbiota of skin and guts of healthy frogs 
but are also known to cause disease (Hird et el., 1981, Pearson, 1998, Taylor, 2001, 
Hayes et al., 2006). Disease development depends on their virulence and environmental 
factors (Glorioso et al., 1974, Rigney et al. 1978, Pearson, 1998, Pearson et al., 2000). 
 
The virulence of bacterial pathogens is usually evaluated using pathogenicity models 
which aim to reproduce disease in vivo by challenging the selected host with bacterial 
isolates. These models enable disease to be monitored and are essential in the comparison 
of virulence of different bacterial isolates (Pearson, 1998). In addition, they can be used 
to evaluate efficacy of prophylactic and chemotherapeutic treatments (Janda, 1991), to
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 investigate the relationship between environmental factors and bacteria in the aetiology 
of disease (Janda, 1991) and to assess the function of immune defences (Woodhams et 
al., 2007). 
 
Two modes of bacterial challenge are used in frog pathogenicity models: injection and 
bath challenge. Injection of pathogens is widely used for analyses of virulence of human 
and animal bacterial isolates but its main flaw is that bacteria are introduced in a manner 
that does not adequately reflect the natural mode of infection (Wise et al., 1993, Pearson, 
1998). Feeding frogs with various bacterial pathogens might resemble a more natural 
mode of infection but it does not result in disease (Glorioso et al., 1974). Under 
experimental conditions it is found that immersion in a bacterial pathogen suspension 
results in disease and appears to more closely simulate the natural mode of infection 
because none of the natural immune defence barriers are by-passed (Pearson, 1998).  
 
Four requirements for proof of virulence of an organism were presented in 1883 by the 
German bacteriologist, Robert Koch. His postulates state that an organism is an causative 
agent of disease if: 
1. It is present in all cases of disease. 
2. It must be isolated from a diseased organism and grown in pure culture. 
3. It causes disease when introduced into a healthy organism.  
4. It must be re-isolated from the inoculated, diseased experimental host and identified as 
being identical to the original specific causative agent. 
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This framework is relatively rigid for demonstrating that a bacterium is a potential 
pathogen. The influences of environmental factors are not considered, although they are 
important in development of bacterial disease of frogs. Despite such limitation, the 
postulates are still a standard by which association of bacteria with disease could be 
established (Thrushfield, 1995). 
 
The aims of this study were to assess the virulence of three bacterial isolates collected 
from wild Litoria ewingii: A. hydrophila, K. pneumoniae and P. mirabilis. Isolates were 
used to challenge L. ewingii and their ability to fulfill the third and fourth Koch’s 
postulates were investigated. 
 
5.2 Material and Methods 
5.2.1 Frogs 
Adult L. ewingii (2.0-2.5 g) were collected in Oxford Forest in January 2008. They were 
maintained in natural conditions in a vivarium. One month before experimentation they 
were transferred to Sistema 7L polypropylene box tanks with a snap lid (350 x 200 x 100 
mm) and maintained as described in section 2.2.7. 
 
5.2.2 Bacterial cultures 
The isolates of A. hydrophila, K. pneumoniae and P. mirabilis were as described in 
section 2.2.4.  
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5.2.3 Calibration curve for bacterial cultures 
A colony from overnight growth on tryptone soya agar was used to inoculate 10 ml of 
tryptone soya broth (TSB). Bacterial cells were harvested by centrifugation at 4,000 g at 
4ºC for 15 min and resuspended in sterile saline (0.85% NaCl). The optical density (at 
610 nm) of bacterial suspension was adjusted with sterile saline to give an optical density 
of 1.2, 1.0, 0.8, 0.6, 0.4, 0.2 and 0.1. At each optical density a sample was taken to 
estimate number of colony forming units (cfu) by overnight incubation on tryptone soya 
agar. The number of cfu was plotted against optical density to give a calibration curve for 
the number of cfu (standard curves are shown in Appendix J). The regression equation 
obtained from the calibration curve was used to estimate the number of cfu in the broth 
cultures.  
 
5.2.4 Preparation of bacterial challenge inoculum 
Cells from an overnight bacterial TSB culture were harvested by centrifugation at 4,000 g 
at 4ºC for 15 min and resuspended in sterile saline. The optical density of bacterial 
suspensions was measured and number of cfu/1 ml of suspension was estimated using the 
calibration curves and bacterial suspensions diluted with sterile saline to give a final 
concentration of 2 x 108 cfu/ml suspension which was used as the inoculum. Sterile saline 
was used inplace of inoculum in control treatments.  
 
5.2.5 Bacterial baths 
Two successive short baths were performed instead of an overnight bath that could 
disturb osmoregulation of arboreal species like L. ewingii. Each animal was put into 300 
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ml of pond water with bacteria at a concentration of 2 x 107 of cfu/1ml of pond water in 
500 ml tissue culture jars and monitored during a 40 min bath. The lid of the jars had 
drilled ventilation holes. Between two baths the animal was put to rest in 7 L empty 
polypropylene tanks for 30 min. After the trial, the animals were returned to their living 
containers and their health was monitored for a period of three weeks.  
 
5.2.6 Euthanasia of animals  
Diseased animals were euthanised by a humane euthanising agent (3% aqueous solution 
of chloral hydrate) to prevent suffering. Samples of liver, heart and spleen were taken for 
culturing bacteria as described in section 2.2.4. At the end of experiment, all animals 
were euthanised and samples of internal organs also taken for bacterial culturing. 
 
5.2.7 Identification of bacteria 
Bacteria from internal organs were identified using the API 20E identification kit 
(Biomérieux, Marcy-L'etoile, France) containing 23 conventional biochemical tests in 
miniaturised forms. It consists of microtubes with dehydrated media which are 
reconstituted with suspension of bacterial cultures. During incubation, metabolism 
produces colour changes that are either direct or revealed by the addition of reagent. The 
strips were inoculated according to the manufacturer’s instructions. In brief:  
• An API strip was placed in a moist incubation tray. 
• A colony from the overnight an overnight soya tryptone agar culture was 
resuspended in 5 ml of sterile saline. 
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• The suspension was aliqouted into the microtube. Those tests requiring anaerobic 
conditions were covered with mineral oil.  
• The strip was covered and incubated overnight at 30°C.  
• The strip was examined and direct reactions were recorded. Additional reagents 
were added when required. 
• The results were read by referring to the manufacturer’s interpretation table in 
API 20 E manual.  
• Four supplementary tests were performed aside the strip: analysis of motility, 
growth on MacConkey agar, oxidation of glucose and fermentation of glucose. 
Information on procedures provided in appendices K–M. 
• The identification of bacteria was carried out with biochemical profiles obtained 
by API 20 E tests and four supplementary tests using Apiweb software 
(Biomérieux, Marcy-L'etoile, France). Information on biochemical profiles 
provided in appendix N. 
 
 
 
 
 
 
 
 
 
Chapter 5: Bath challenges with bacterial isolates from wild frogs  
 
 92
5.3 Results 
Morbidity and mortality were recorded only in K. pneumoniae challenge. Two animals 
developed disease two days after exposure and died seven days after exposure (Table 5). 
They had gross clinical signs of disease including haemorrhages, ulcers and redness of 
the ventral skin area (Fig. 5). The challenge bacterium was isolated as a pure culture from 
their heart, spleen and liver. The remaining animals in the K. pneumoniae challenge and 
all of the animals in the two other challenges and control group remained healthy until the 
end of the experiment (Table 5). Samples from their internal organs were negative for 
bacterial growth.  
 
 
 
 
 
  93
Table 5 Mortality of L. ewingii following bath challenges with 2 x 107cfu/1 ml of pond water of A. hydrophila, K. pneumoniae and P. 
mirabilis. 
 
Treatment 1 day 2 days 3 days 4 days 5 days 6 days 7 days Final mortality (%)
A. hydrophila (N = 5) 0 
 
0 0 0 0 0 0 0 
K. pneumoniae (N = 5) 
 
 
0 
 
0 0 0 0 0 2 40 
P. mirabilis (N = 5) 
 
 
0 0 0 0 0 0 0 0 
Control (N = 5) 0 0 0 0 0 0 0 0 
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Fig. 5 Gross clinical signs of L. ewingii infected with K. pneumoniae: body posture (A), skin ulcer 
(B) and prominent redness of ventral skin (C). 
 
 
 
 
Chapter 5: Bath challenges with bacterial isolates from wild frogs  
 
 95
5.4 Discussion 
The results from this study demonstrated the virulence of K. pneumoniae towards L. ewingii. 
K. pneumoniae was isolated from diseased L. ewingii, grown in pure culture, induced disease 
in healthy individuals and was re-isolated to fulfill three of four Koch’s postulates for disease 
caused by this microorganism. The animals developed septicemic disease and the bacterium 
was re-isolated from the diseased animals (Fig. 5; Table 5).  
 
The septicemic disease demonstrated by the infected frogs was slow progressing confirming 
the results of Pearson (1998) who found that the bacterial baths of frogs with Aeromonas sp. at 
doses of 106 cfu caused slowly progressing septicemic disease while Aeromonas injection 
caused a rapid septicemic disease and death within twenty-four hours. Slow progression of 
disease in the bath challenge might be due to the time taken for developing skin infections 
preceding systematic bacterial dissemination (Pearson, 1998). 
 
K. pneumoniae is not a frog specific pathogen although its virulence was demonstrated for L. 
ewingii (Fig. 5; Table 5). This bacterium has been associated with disease outbreaks in humans 
and different animals (Enurah et al., 1988, Brisse and Van Duijkeren, 2005, Munoz et al., 
2006, Castinel et al., 2007). Different mammalian species have been described to become 
infected by contaminated water or soil as the bacterium can survive for a long time outside of 
its host (Enurah et al., 1988, Munoz et al., 2006, Castinel et al., 2007). The ability of these 
animals to resist infection depends on different mechanisms of the innate immune defences as 
the adaptive immune defences cannot provide a rapid efficient response to the high number of 
invading pathogens (Yoshida et al., 2001, Cortès, et al., 2002). The observation that L. ewingii, 
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the only introduced Litoria species that does not have the active antimicrobial peptide of the 
skin innate immunity (described in chapter two), is susceptible to disease both in the wild 
(Schadich unpubl. data) and in bath challenges (Fig. 5; Table 5) supports a role for the innate 
immune defences of frogs in protection from K. pneumoniae. 
  
Virulence of the isolates of A. hydrophila and P. mirabilis that did not cause disease of L. 
ewingii cannot be ruled out at this stage since bath challenges without skin scarification might 
underestimate it. Somsiri et al. (1997) reported that skin scarification is required for 
demonstration of virulence of some frog bacterial isolates. In addition, the virulence of isolates 
was tested only at a bacterial dose of 2 x 107 cfu/ 1 ml of pond of water and different bacterial 
doses might give different results. Thus a more sensitive bath challenge model with skin 
scarification of tested frogs and different doses of challenge bacteria would be required to rule 
out the possibility that these isolates are in fact potentially virulent. 
 
Environmental stressors have profound and diverse effects on the immune defences of frogs. 
Their inhibitory effects on resistance to disease have been demonstrated in many different 
studies (Rigney et al. 1978, Carey and Bryant, 1995, Taylor et al. 2001, Hayes et al. 2006). 
Somsiri et al. (1997) found that low temperature was one of the most significant stressors that 
increased morbidity and mortality of frogs in bath challenges with A. hydrophila. One direction 
of future studies should include an analysis of the role of low temperature in disease resistance 
of frogs. 
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Chapter 6: Effects of the Pesticide Carbaryl and the Bacterial 
Pathogen Klebsiella pneumoniae on Production of Skin Peptides 
 
6.1 Introduction 
Among different pollutants, pesticides have most often been cited as having a primary  role in 
amphibian decline (Davidson et al., 2004, Davidson and Knapp, 2007). The decline of four 
Rana species: R. boylii, R. cascadae, R. draytonii and R. muscosa have been observed in a 
region with intensive pesticide drifts (Drost and Fellers, 1996, Davidson et al., 2004, Davidson 
and Knapp, 2007). The documented levels of various pesticides in these regions of decline are 
generally of several orders of magnitude below the lethal concentrations as determined in 
laboratory studies (Davidson et al., 2004). However, sub-lethal concentrations of different 
pesticides including two common pesticides: the herbicide atrazine and the insecticide carbaryl 
can affect different physiological processes of frogs including their immune defences. In Rana 
pipiens, exposure to atrazine caused suppression of both adaptive and innate immune defences 
as shown by decreased antibody production (Gilbertson et al., 2003) and phagocytic activity of 
white blood cells respectively (Brodkin et al., 2007). In R. boylii, exposure to carbaryl caused 
reduced production of the antimicrobial peptides of the skin immune defences (Davidson et al., 
2007). Thus, if pesticides are implicated in amphibian decline, it is probably due to synergistic 
effects with other factors such as disease. 
 
Bacterial dermatosepticemia, a bacterial infectious disease, has been observed to affect 
populations of the introduced Litoria species L. ewingii in Oxford Forest, Canterbury 
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(Schadich unpubl. data). Bacteria isolated from diseased frogs, K. pneumoniae, were able to 
fulfill Koch’ postulates (described in Chapter 5) and this suggests it could also pose a risk to 
another introduced Litoria species, L. raniformis, which is also found in this region. Resistance 
to disease could depend on effective immune defences such as the antimicrobial peptides of the 
skin innate immune defences (Simmaco et al., 1998, Rollins-Smith et al., 2005, Woodhams et 
al., 2006, Woodhams et al., 2007). Although an extensive analysis showed that L. raniformis 
had more efficient skin peptides than L. ewingii (described in Chapter 2), it is possible that, in 
the regions of the South Island of New Zealand affected by pesticide drift, exposure to 
pesticides could inhibit skin peptides and thereby increase susceptibility of L. raniformis to 
disease (Stevens, 1993, Holland and Rahman, 1999, Davidson and Knapp, 2007). 
 
The aim of this study was to assess the possible effects of the pesticide carbaryl and the 
bacterium K. pneumoniae on production and activity of skin peptides, and disease development 
of L. raniformis.  
 
6.2 Materials and methods 
6.2.1 Frogs  
Adult L. raniformis (26-33 g) were purchased from the commercial supplier Sweet Koura 
Enterprises, Alexandra in December 2007. The animals were maintained in natural conditions 
in a vivarium. One month before experiment they were transferred in Sistema 7L 
polypropylene box tanks with a snap lid (350 x 200 x 100 mm) and maintained as described in 
Section 2.2.7. 
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6.2.2 Bacterial culture 
The isolate of K. pneumoniae from wild L. ewingii was as described in section 2.2.4. 
 
6.2.3 Carbaryl  
Carbaryl (98% purity) was purchased from Kiwi Care Ltd, Christchurch.  
 
6.2.4 Exposure to carbaryl and K. pneumoniae  
L. raniformis frogs were assigned to four different groups of twenty labelled according to 
assigned treatment: carbaryl, K. pneumoniae, carbaryl and K. pneumoniae and control. On the 
first day of the trial, carabaryl and carbaryl and K. pneumoniae groups were exposed to 
carbaryl. Each animal was placed into a container with 3.5 L of pond water with carbaryl at the 
ecologically relevant concentration of 0.48 mg/L in a 7L tanks that allowed the animals to 
swim or to stand with its head above the surface water and monitored during a 16 h exposure. 
The lids of the containers had drilled ventilation holes. After exposure, frogs were returned to 
the container in which they were normally kept. On the second day, K. pneumoniae and 
carbaryl and K. pneumoniae groups were exposed to K. pneumoniae as described by Pearson 
(1998). Each animal was placed into a container with 3.5 L of pond water with K. pneumoniae 
at a concentration of 2 x 107colony forming units for 16 h. The control group was exposed only 
to pond water both on the first and second days. After exposure, the animals were returned to 
their living tanks and monitored for survival for the period of three weeks. Skin peptides were 
collected twenty-four days before and two days after exposure to carbaryl or one day after 
exposure to K. pneumoniae. In order to exclude the possible effects of peptide collection on 
survival, four additional groups were exposed to carbaryl, K. pneumoniae, carbaryl and K. 
pneumoniae and pond water respectively but without collection of skin peptides.  
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Procedures for inducing, collecting and purifying skin peptides are described in Section 2.2.1. 
The quantity of skin peptides recovered and their activity against the isolate of K. pneumoniae 
were measured for each animal as described in Sections 2.2.1, 2.2.2, 2.2.5 and 2.2.6 
respectively. Differences between the two groups of animals in total recovered peptides, MIC, 
MIC equivalents per gbm and surface area were tested by the nonparametric Kruskal-Wallis 
rank and Mann-Whitney U-tests.  
 
6.2.5 LC-MS analyses of skin peptides profiles of L. raniformis exposed to carbaryl and K. 
pneumoniae  
Liquid chromatography mass spectrometry (LC-MS) analyses of the samples of the natural 
peptide mixtures were carried out by the same procedure as described in Section 2.2.3. 
 
6.3 Results 
6.3.1 Effects of carbaryl and K. pneumonia on survival  
Morbidity and mortality was not observed either in any individual from treated or control 
groups of L. raniformis.  
 
6.3.2 Effects of carbaryl and K. pneumoniae on skin peptide defences  
Before exposures of L. raniformis to K. pneumoniae, carbaryl and the combination of the two, 
no difference was found between the future exposed and control animals with respect to the 
following variables: the average total amount of recovered peptide (Kruskal-Wallis rank test, 
X23  = 0.80, P = 0.850), the MIC of peptide mixtures against K. pneumoniae (Kruskal-Wallis 
rank test, X23  = 0.64, P = 0.887), MIC equivalents per gbm (Kruskal-Wallis rank test, X23  = 
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1.39, P = 0.707) and MIC equivalents per cm2 (Kruskal-Wallis rank test, X23  = 2.17, P = 0.537) 
(Table 6.1). After exposure, the total amount of recovered peptides and MIC equivalents per 
gbm and cm2 of the exposed animals depended on the exposure. Animals exposed to K. 
pneumoniae had a significantly higher average of total recovered peptides (Mann-Whitney U-
test, Z = –3.41, N = 40, P < 0.016), MIC equivalents per gbm (Mann-Whitney U-test, Z = –
3.00, N = 40, P < 0.016) and MIC equivalents per cm2 (Mann-Whitney U-test, Z = –2.89, N = 
40, P < 0.016) than control animals (Figs. 6.1. and 6.2; Table 6.2). Animals exposed to carbaryl 
had a significantly lower average of total recovered peptides (Mann-Whitney U-test, Z = –5.36, 
N = 40, P < 0.016), MIC equivalents per gbm (Mann-Whitney U-test, Z = –5.08, N = 40, P < 
0.016) and MIC equivalents per cm2 (Mann-Whitney U-test, Z = –5.14, N = 40, P < 0.016) than 
control animals (Figs. 6.1 and 6.2; Table 6.2). Animals exposed to K. pneumoniae and carbaryl 
also had a significantly lower average of total recovered peptides (Mann-Whitney U-test, Z = –
5.41, N = 40, P < 0.016), MIC equivalents per gbm (Mann-Whitney U-test, Z = –5.22, N = 40, 
P < 0.016) and MIC equivalents per cm2 (Mann-Whitney U-test, Z = –5.22, N = 40, P < 0.016 
than control animals (Figs. 6.1 and 6.2; Table 6.2). No difference was found between the 
exposed and control animals in average MIC (Kruskal-Wallis rank test, X23  = 0.44, P = 0.933; 
Fig 6.3, Table 6.2). None of the peptide digests obtained by proteolysis of skin peptides 
inhibited bacterial growth.
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Table 6.1 Production of skin peptides and peptide efficiency against K. pneumoniae of L. raniformis before exposure to carbaryl and K. 
pneumoniae, and carbaryl and K. pneumoniae simultaneously. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment No animals Total peptides 
 per 1g body weight 
 ((µg/g) +/-SD ) 
MIC (µg/ml) 
 +/- SD 
 
MIC equivalents 
 per 1g body weight 
( and +/-SD 
MIC equivalents 
 per cm2 surface 
area ( and +/-SD) 
Pond water only  
(Control) 
20 79.03 +/- 9.87 262.50 +/- 55.90 0.308 +/- 0.053 0.158 +/- 0.025 
K. pneumoniae  20 80.88 +/- 6.95 256.25 +/- 63.80 0.330 +/- 0.076 0.169 +/- 0.041 
Carbaryl  
 
20 80.77 +/- 10.24 256.25 +/- 63.80 0.332 +/- 0.100 0.169 +/- 0.048 
Carbaryl and  
 K. pneumoniae 
 
20 80.53 +/- 7.67 262.50 +/- 55.90 0.314 +/- 0.048 0.160 +/- 0.024 
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Table 6.2 Production of skin peptides and peptide efficiency against K. pneumoniae of L. raniformis exposed to carbaryl and K. 
pneumoniae, and carbaryl and K. pneumoniae simultaneously. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment N animals Total peptides 
per 1g body weight 
 ((µg/g) +/-SD ) 
MIC (µg/ml) 
 +/- SD 
 
MIC equivalents 
 per 1g body weight 
( and +/-SD 
MIC equivalents 
 per cm2 surface 
area ( and +/-SD) 
Pond water only  
(Control) 
20 79.70 +/- 11.89 262.50 +/- 55.90 0.310 +/- 0.057 0.159 +/- 0.027 
K. pneumoniae  20 95.02 +/- 12.77 268.75 +/- 83.85 0.379 +/- 0.107 0.193 +/- 0.053 
Carbaryl  
 
20 48.82 +/- 13.08 262.50 +/- 55.90 0.189 +/- 0.053 0.096 +/- 0.026 
Carbaryl and  
 K. pneumoniae 
 
20 45.56 +/- 10.36 275.00 +/- 76.95 0.171 +/- 0.044 0.087 +/- 0.021 
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Fig. 6.1 Comparison of total recovered peptides of L. raniformis after exposure to pond water only (control), carbaryl, K. pneumoniae 
and carbaryl and K. pneumoniae simultaneously.  
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Fig. 6.2 Comparison of MIC equivalents of L. raniformis after exposure to pond water only (control), carbaryl, K. pneumoniae and 
carbaryl and K. pneumoniae simultaneously.  
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Fig. 6.3 An example of growth inhibition K. pneumoniae by skin peptides from L. raniformis 
exposed to pond water only (control) (A), K. pneumoniae (B), carbaryl (C) and carbaryl and K. 
pneumoniae (D). 
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6.3.3 Skin peptide profiles of L. raniformis after exposure to carbaryl and K. pneumoniae 
Skin peptide profiles obtained by LC-MS were not markedly different among treated and 
control animals. The peptide mixtures from all had the peptides whose molecular masses (Mr) 
correspond to that of eight different aurein peptides: aurein 1.1 (Mr = 1444.48 Da), aurein 1.2 
(Mr = 1479.27 Da), aurein 2.1 (Mr = 1614.53 Da), aurein 2.5 (Mr = 1646.49 Da), aurein 2.6 (Mr 
= 1627.65 Da), aurein 3.1 (Mr = 1737.59 Da), aurein 3.2 (Mr = 1767.67 Da) and aurein 5.2 (Mr 
= 2449.73 Da) (Fig. 6.4). 
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Fig. 6.4 LC-MS analyses of peptide mixtures from L. raniformis: exposed to pond water only 
(control) (A), K. pneumoniae (B), carbaryl (C) and carbaryl and K. pneumoniae (D). 
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6.4 Discussion 
Based on the results presented in this chapter, L. raniformis frogs might be well protected from 
bacterial disease induced mortality even in the presence of pesticide. Exposure to either 
pathogenic K. pneumoniae alone or in combination with carbaryl did not result in disease 
development. The ability of L. raniformis frogs to defend themselves from pathogenic disease 
may be attributable to the efficiency of their antimicrobial skin peptides. The natural mixture of 
skin peptides inhibited the growth of K. pneumoniae in vitro (Fig. 6.3). Although the total 
amount of recovered peptides was significantly decreased after exposure to carbaryl and K. 
pneumoniae, it was within the range that could provide significant protection (Figs. 6.1–6.3; 
Table 6.2). Thus, no interaction was observed between carbaryl and K. pneumoniae with 
respect to disease susceptibility.  
 
6.4.1 Skin peptide response to K. pneumoniae 
Skin peptide defences of L. raniformis to invading pathogens could be inducible as the total 
amount of recovered peptides was increased after exposure to K. pneumoniae (Fig. 6.1; Table 
6.2). These results confirm the results of Simmaco et al (1998) who found that production of 
skin peptides of Rana esculenta increased after exposure to A. hydrophila through a response 
mechanism that includes the nuclear transcription factor (NF-κB factor) involved in activation 
of peptide synthesis in the granular glands (Miele et al., 1998, Simmaco et al., 1998). 
However, inhibition of this mechanism by corticosteroid hormones associated with stress could 
increase susceptibility to disease (Miele et al., 1998, Simmaco et al., 1998).  
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6.4.2 Carbaryl mediated inhibition of skin peptide defences 
The observation that acute exposure of L. raniformis to carbaryl induced a decrease in total 
amount of recovered peptides shows that carbaryl can inhibit skin peptide defences. Since the 
frogs are more likely to experience multiple exposure in the wild that could have stronger 
inhibitory effects on skin peptide defences than acute exposures, carbaryl could potentially 
increase susceptibility to disease.  
 
Decrease in total amount of recovered peptides was not associated with a decrease in peptide 
activity, nor with any change in the composition of the natural peptide mixtures, based on LC-
MS (Figs. 6.3 and 6.4; Table 6.2). This supports the hypothesis of Davidson et al. (2007), that 
carbaryl could decrease peptide deposits in granular glands. This hypothesis was based on the 
results of experimental studies that showed carbaryl mimics the effects of norepinephrine on 
short circuit currents (SCC) in skin.  In Rana esculenta, bathing isolated frog skin in relatively 
low concentrations of carbaryl induced increased SCC due to secretion of chloride ions (Cl–), 
which might be an important stimulus for release of peptides from granular glands (Ardizzone 
et al., 1990, Lippe et al., 1992, Erspamer, 1994). Prolonged alterations of SCC could 
significantly reduce peptide deposits in granular glands. Further histological and chemical 
studies should a reveal mechanism of effect of carbaryl on reduction of peptide deposits in 
granular glands.  
 
The significance of inhibition of skin peptide defences by carbaryl for susceptibility to disease 
of the frogs in the wild might be dependent on a number of different factors. Metamorphs 
might be more susceptible to effects of carbaryl than adult frogs as the total amount of 
recovered peptides of R. boylii after exposure to carbaryl was decreased five-fold (Davidson et 
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al., 2007) while the total amount of recovered peptides of adult L. raniformis after exposure to 
carbaryl decreased less than 50% (Fig. 6.1; Table 6.2). An important factor that could 
contribute to susceptibility of skin peptide defences of metamorphs to carbaryl could be the 
high level of corticosteroids that are associated with metamorphic events (Rollins-Smith, 
1998). Some species with less efficient skin peptide defences might be more vulnerable to 
carbaryl than species with efficient skin peptide defences such as Xenopus laevis (described in 
Chapter 2). In addition, the effects of carbaryl could be enhanced through interactions with 
environmental conditions such as temperature fluctuations and UV light (Blaustein et al. 1998, 
Belden and Blaustein, 2002, Beecher, 2006). Inhibition of skin peptide defences might be of 
greater significance for increased susceptibility to virulent pathogens such as chytrid fungi and 
pathogenic bacteria. These facts prompt directions for futures studies that should focus on how 
species, age, pathogen virulence and different environmental conditions could affect the 
carbaryl induced inhibition of skin peptide defences of frogs.  
 
Due to intensive usage of different pesticides and subsequent pesticide drift, frogs could be 
exposed to different pesticides that could affect skin peptide defences. Gibble et al (2006) 
found that exposure of metamorphs of X. laevis to atrazine significantly reduced the efficiency 
of skin peptide against chytrid fungi. Atrazine could have a different effect on skin peptide 
defences than carbaryl as it might influence peptide synthesis by increasing the blood level of 
corticosteroids (Hayes et al., 2003, Simmaco et al., 1998). Thus, different pesticides could 
affect different aspects of the skin peptide defence system.  
 
Hayes et al (2006) demonstrated that exposure of tadpoles to pesticide mixtures increased 
susceptibility to disease caused by the bacterium C. meningosepticum, while exposure to each 
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of these pesticides solely did not increase disease development. Tadpoles are likely to have 
more susceptible immune defence to pesticides than metamorphs and adults due to less 
developed innate and adaptive immune defences (Flajnik et al., 1986, Flajnik et al., 1987, 
Pross and Rowlands, 2005). However, it is plausible that exposure to different pesticides in 
mixtures might cause both additive and synergetic harmful effects in adults and metamorphs as 
well, so further research should be directed in this area. 
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Chapter 7: Concluding Discussion 
 
The central aims of this study were to determine whether the antimicrobial peptides from skin 
granular glands of three semi-aquatic Litoria frog species L. aurea, L. raniformis and L. 
ewingii and aquatic Xenopus laevis could have a function against bacterial pathogens 
associated with bacterial dermatosepticemia, and to investigate whether five different factors: 
phylogeny, life stage, pathogen, low temperature and pesticides could influence such a 
function. As disease is caused by different pathogens (Glorioso et al., 1974, Anver and Pond, 
1984, Olson et al., 1992, Taylor et al., 2001), the activity of skin peptides was tested against 
eight different pathogens including: Aeromonas hydrophila, Chryseobacterium 
meningosepticum, Citrobacter freundii, Klebsiella pneumoniae, Proteus mirabilis, 
Pseudomonas aeruginosa and Serratia liquefaciens. The single peptides and natural mixture of 
skin peptides of three species: L. raniformis and Litoria aurea and Xenopus laevis had activity 
against more than one pathogen including Citrobacter freundii, Chryseobacterium 
meningosepticum, Klebsiella pneumoniae and Pseudomonas aeruginosa in vitro. This could 
provide significant protection in vivo. The presence of effective skin peptides in different frog 
species indicates they are a conserved mechanism of immune defence. The role of skin 
peptides in protection from disease is supported by fact that the activity of these skin peptides 
correlates well with resistance to disease. L. ewingii, whose skin peptides did not have activity 
against any bacterial pathogen, was susceptible to disease both in the wild (Schadich unpubl. 
data) and following experimental exposure to the pathogen K. pneumoniae, while L. raniformis 
was resistant to that pathogen. The protection from disease provided by skin peptides,
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 however, could be context-dependent, since it was found that all five tested factors strongly 
influence their effectiveness. 
 
The immune function against bacterial pathogens of the aquatic species X. laevis might be 
more efficient than those of three tested semi-aquatic Litoria species in terms of production 
and activity of skin peptides. X. laevis produced a significantly greater amount of skin peptides 
than L. aurea and L. raniformis while L. ewingii did not have active peptides. Similarly, the 
peptide mixture of X. laevis had greater activity against bacterial pathogens than all three tested 
Litoria species. The greater activity of peptide mixture correlated with its greater diversity, as 
observed by LC-MS analyses. The significance of peptide diversity was also supported by the 
observation that the peptide mixture of L. ewingii, which was not active against any tested 
pathogen, had the smallest peptide diversity.  
 
Three pathogens: A. hydrophila, P. mirabilis and S. liquefaciens showed resistance to skin 
peptides tested. For one pathogen, A. hydrophila, it was demonstrated that resistance to skin 
peptides was associated with extracellular proteases. Since all three resistant bacterial species 
were also a component of the microbiota of skin of healthy frogs (Hird et al., 1981, Taylor et 
al., 1993, Taylor et al., 2001), resistance to such peptides might have a role in their relationship 
with their hosts. The regulation of these pathogens could include defence mechanisms other 
than skin peptides such as microbial antagonism and macrophages of skin and lymphatic 
sinuses.  
 
The analyses of skin peptides of L. ewingii as adults, metamorphs and larvae showed that 
postmetamorphic animals, adults and metamorphs secrete a peptide mixture with a species-
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specific profile that includes the antimicrobial peptide uperin 7.1, while the larval peptide 
mixture did not contain uperin 7.1 or any other known species-specific peptide. These 
differences in skin peptides between adults, metamorphs and larvae indicates the absence of a 
secretory mechanism that could compensate for the absence of granular glands in larvae. Since 
the onset of skin secretions in metamorphosis is a conserved physiological process (Delfino, 
1991, Erspamer, 1994, Viertel and Richter, 1999), the differences in skin peptides among 
different life stages of L. ewingii are relevant when considering activity of skin peptides in the 
different life stages of other frogs species.  
 
Both low temperature and the pesticide carbaryl were shown to have the ability to modulate the 
function of skin peptides of L. raniformis. The endpoint of their effect is in lowering the 
amount of bio-active skin peptides induced on the skin surface, which can significantly 
suppress the immune activity against invading pathogens. The intensity of carbaryl-induced 
suppression of skin peptides is sufficiently strong to disrupt the conserved response mechanism 
of frogs to increase the amount of induced peptides in response to K. pneumoniae challenge. 
As the skin peptides are the only effective defence of frogs against the frog specific pathogen 
Batrachochytrium dendrobatidis (Rollins-Smith et al. 2002, Woodhams et al., 2006, 
Woodhams et al., 2007), a reduced level of skin peptides could substantially impair the 
immune response against this pathogen. Therefore, the results of this study, showed that both 
low temperature and pesticide could suppress the innate immune defences of frogs in a manner 
that could potentially increase susceptibility both to general pathogens such as opportunistic 
bacteria and to frog-specific pathogens. 
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Appendix A: LC-MS/MS Analyses of Peptides of X. laevis 
 
            Table A. LC-MS/MS analyses of peptides of X. laevis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Footnote: No. is the accession number of the peptide sequence in the NCBI database. AA is the total 
number of amino acids of the distinct peptide. Position of peptide fragments in distinct peptides are 
denoted by /. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distinct peptide No. AA Peptide fragment 
CPF 1 gi|115430 27 1-10/GFGSFLGKAL 
11-27/KAALKIGANALGGSPQQ 
CPF 2 gi|115435 27 1-10/GFASFLGKAL 
11-27/KAALKIGANMLGGTPQQ 
CPF 3 
 
gi|115432 27 1-10/GLASLLGKAL 
3-14/ASLLGKALKAGL 
15-27/KIGTHFLGGAPQQ 
CPF 4 gi|115434 27 1-10/GLASFLGKAL 
3-14/ASFLGKALKAGL 
11-27/KAGLKIGAHLLGGAPQQ 
15-27/KIGAHLLGGAPQQ 
PGL gi|65026 21 1-18/GMASKAGAIAGKIAKVAL 
5-21/KAGAIAGKIAKVALKAL + Amide (C-term) 
6-21/AGAIAGKIAKVALKAL.+ Amide (C-term) 
12-21/KIAKVALKAL + Amide (C-term) 
LPF gi|126222 25 1-11/GWASKIGQTLG 
12-25/KIAKVGLQGLMQPK 
Magainin I gi|126683 23 1-10/GIGKFLHSAG 
11-23/KFGKAFVGEIMKS 
14-23/KAFVGEIMKS 
Magainin II gi|126683 23 1-7/GIGKFLH 
1-10/GIGKFLHSAK 
11-23/KFGKAFVGEIMN 
14-23/KAFVGEIMNS 
PGQ gi|236997 24 1-11GVLSNVIGYLK 
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Appendix B: LC-MS/MS Analyses of Peptides of L. aurea 
 
Table B. LC-MS/MS analyses of peptides of L. aurea.  
 
Aurein  No. AA Peptide fragment 
2.2 
 
gi|20137309 16 1-8/GLFDIVKK 
1-11/GLFDIVKKVVG 
3-11/FDIVKKVVG 
3-16/FDIVKKVVGALGSL+ Amide (C-term)  
2.3 gi|20137310 16 1-8/GLFDIVKK 
1-11/GLFDIVKKVVG 
3-16/FDIVKKVVGAIGSL+ Amide (C-term)  
2.4 gi|20137311 16 1-8/GLFDIVKK 
1-9/GLFDIVKKV 
1-11/GLFDIVKKVVG 
3-11/FDIVKKVVG 
3-16/FDIVKKVVGTIAGL+ Amide (C-term) 
2.5 gi|68053337 16 1-8/GLFDIVKK 
1-11/GLFDIVKKVVG 
3-11/FDIVKKVVG 
3-16/FDIVKKVVGAFGSL+ Amide (C-term) 
3.1 gi|68053340 17 1-8/GLFDIVKK 
3-17/FDIVKKIAGHIAGSI+ Amide (C-term) 
3.2  gi|68053342 17 1-7/GLFDIVK 
1-8/GLFDIVKK 
3-8/FDIVKK 
1-9/GLFDIVKKI 
1-11/GLFDIVKKIAG 
3-11/FDIVKKIAG 
1-12/GLFDIVKKIAGH 
1-14/GLFDIVKKIAGHIA 
1-16/GLFDIVKKIAGHIASS 
5.2 gi|57975125 25 1-11/GLMSSIGKALG 
5-24/SIGKALGGLIVDVLKPKTPA 
8-24/KALGGLIVDVLKPKTPA 
12-24/GLIVDVLKPKTPA 
12-25/GLIVDVLKPKTPAS 
 
 
Footnote: No. is the sequence number of the aurein peptides sequences in the NCBI database. AA is the 
total number of amino acids of the distinct aureins. Position of peptide fragments in peptide sequence 
are denoted by /. 
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Appendix C: LC-MS/MS Analyses of Peptides of L. raniformis 
 
Table C. LC-MS/MS analyses of peptides of L. raniformis. Table agenda as in Table B (Appendix 
B)  
 
                           
Footnote is as in Table B (Appendix B). 
 
 
 
Appendix D: LC-MS/MS Analyses of Peptides of L. ewingii 
 
    Table D. LC-MS/MS analyses of peptides of L. ewingii. Table agenda as in Table A (Appendix 
A)  
 
 
Footnote is as in Table A (Appendix A). 
 
 
 
 
Aurein No. AA Peptide fragment 
1.2 gi|20137307 13 1-11/GLFDIIKKIAE 
3-13/FDIIKKIAESF+ Amide (C-term 
4-14/DIIKKIAESF+ Amide (C-term) 
2.1 
 
gi|68053336 16 1-11/GLLDIVKKVVG 
2-16/LDIVKKVVGAFGSL+ Amide (C-term) 
2.6 gi|20137313 16 1-11/GLFDIAKKVIG 
3.1  gi|68053340 17 1-8/GLFDIVKK 
3-17/FDIVKKIAGHIAGSI+ Amide (C-term) 
3.2 gi|68053342 17 1-7/GLFDIVK 
1-8/GLFDIVKK 
3-8/FDIVKK 
1-9/GLFDIVKKI 
1-11/GLFDIVKKIAG 
3-11/FDIVKKIAG 
1-12/GLFDIVKKIAGH 
1-14/GLFDIVKKIAGHIA 
3.3 
 
gi|20137316 17 1-7/GLFDIVK 
1-8/GLFDIVKK 
3-11/FDIVKKIAG 
1-11/GLFDIVKKIAG 
5.2 gi|57975125 25 1-11/GLMSSIGKALG 
5-24/SIGKALGGLIVDVLKPKTPA 
8-24/KALGGLIVDVLKPKTPA 
12-24/GLIVDVLKPKTPA 
12-25/G.GLIVDVLKPKTPAS 
Distinct peptide No. AA Peptide fragment 
Uperin-7.1 
 
gi|7994724 13 1-7/GWFDVVK 
1-8/GWFDVVKH 
3-10/FDVVKHIA 
3-13/FDVVKHIASAV + Amide (C-term) 
4-13/DVVKHIASAV + Amide (C-term) 
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Appendix E: List of Peptide Masses in Peptide Digest of X. laevis 
 
Table E. List of molecular masses of peptide digests of X. laevis. Peaks of LC-MS analyses are 
labelled by numbers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix F: List of Peptide Masses in Peptide Digest of L. aurea 
 
Table F. List of Molecular masses of peptide digests L. aurea. Table agenda as in Table E (Appendix 
E).   
Peak Mr (Da) 
1 703.29 
899.06 
1094.87 
2 784.20 
899.06 
3 330.90 
390.95 
4 245.92 
376.92 
390.96 
5 447.84 
1022.85 
 
 
 
 
 
 
Peak Mr (Da) 
1 821.76 
2 801.10 
996.90 
1208.76 
 3 801.13 
1467.18 
4 330.8 
5 557.77 
972.59 
1431.26 
6 487.799 
905.61 
972.59 
1431.59 
7 369.18 
387.91 
445.77 
626.77 
1160.73 
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Appendix G: List of Peptide Masses in Peptide Digest 
 of L. raniformis 
 
Table G. List of Molecular masses of peptide digests L. raniformis. Table agenda as in Table E 
(Appendix E).   
 
Peak Mr (Da) 
1 594.94 
742.02 
2 703.31 
3 524.94 
785.92 
4 343.88 
444.87 
5 488.81 
1127.72 
6 975.02 
7 341.96 
383.94 
456.88 
739.84 
8 447.64 
564.90 
1039.58 
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Appendix H: List of Peptide Masses in Peptide Digest of L. ewingii 
 
Table H. List of Molecular masses of peptide digests L. ewingii. Table agenda as in Table E 
(Appendix E).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peak Mr (Da) 
1 508.48 
605.35 
686.21 
1192.70 
2 204.95 
443.80 
507.50 
3 255.95 
390.95 
4 261.90 
431.87 
487.83 
519.89 
603.76 
5 272.92 
413.92 
457.95 
460.02 
478.85 
1171.78 
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Appendix I: List of Peptide Masses in Peptide Digest of 
Metamorphs of L. ewingii 
 
Table F. List of Molecular masses of peptide digests of metamorphs (A) and adults (B) of L. 
ewingii. Table agenda as in Table E (Appendix E).  
 
A.                                   B. 
Peak Mr (Da) 
1 446.42 
811.30 
2 909.34 
593.18 
3 909.34 
4 1848.78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peak Mr (Da) 
1 508.48 
605.32 
204.95 
2 204.95 
443.80 
507.50 
3 431.87 
4 431.87 
603.76 
5 478.85 
117.78 
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Appendix J: Calibration Curves for Bacterial Counts 
 
 
Fig. F Calibration curves for counting colony forming units of A. hydrophila (A), K. pneumoniae 
(B) and P. mirabilis (C). 
 
 
 
 
Appendices 
 133
Appendix K: Assessment of Bacterial Motility  
 
Bacterial inoculum was stabbed in the centre and to 2/3 the depth of API M medium 
(Biomérieux, Marcy-L'etoile, France). The samples were incubated for 18 h at 30ºC and 
bacterial growth was examined visually. Diffuse circular bacterial growth from the line of stab 
shows positive test.  
 
Appendix L: Bacterial Growth on MacConkey Agar 
Bacterial suspension was spread onto plates of  MacConkey agar and incubated for 18 h at 
30ºC. After incubation the growth was examined visually. 
 
Appendix M: Glucose Oxidation/ Fermentation (O/F) test 
Glucose oxidation fermentation test (O/F) test demonstrates the ability of bacteria to 
metabolise glucose aerobically (by oxidation) or anaerobically (by fermentation). Tests was 
performed using O-F basal medium (Difco, Lawrence, KS, USA) with 1% glucose. A loopful 
of bacterial suspension was inoculated into ten ml of medium in two test tubes. Sterile liquid 
paraffin was added to a depth of 1 cm in one tube while the other was left uncovered. Tubes 
were incubated overnight at 30ºC. Results were interpreted as follows: 
 
Test Open tube Covered 
Oxidation Yellow Green 
Fermentation Yellow Yellow 
No reaction Blue/Green Green 
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Appendix N: Biochemical Profiles of Bacteria Isolated from 
Diseased L. ewingii in K. pneumoniae Challenge 
Table 5.2. Results of API 20 E strip tests and four supplementary tests for bacteria isolated from 
diseased L. ewingii in K. pneumoniae challenge.  
 
 Bacteria from infected 
tissues (N = 2 animals) 
Test 
Heart Liver Spleen
Challenge Bacteria 
β-galactosidase + + + + 
Arginine dihydrolase – – – – 
Lysine decarboxylase + + + + 
Ornithine decarboxylase – – – – 
Citrate utilisation + + + + 
H2S production – – – – 
Urea + + + + 
Tryptophane deaminase – – – – 
Indole production – – – – 
Voges-Proskauer + + + + 
Gelatin hydrolysis – – – – 
D-glucose + + + + 
D-mannitol + + + + 
Inositol + + + + 
D-sorbitol + + + + 
L-rhamnose + + + + 
D-surcose + + + + 
D-melibiose + + + + 
amygdalin + + + + 
L-arabinose + + + + 
Cytochrome oxidase – – – – 
NO2 production + + + + 
Reduction to N2 – – – – 
Motility* – – – – 
Growth on MacConkey medium* + + + + 
Fermentation on glucose*  + + + + 
Oxidation of glucose*  + + + + 
 
Footnote: * denotes supplementary test. 
 
 
 
 
 
